PMC:1472690 / 21540-23726 JSON TXT

Annnotations TAB JSON ListView MergeView

pmc-enju-pas

Id	Subject	Object	Predicate	Lexical cue
T25791	2146-2147	-RRB-	denotes	)
T25790	2142-2146	CD	denotes	0.01
T25789	2140-2141	SYM	denotes	<
T25788	2138-2139	NN	denotes	p
T25787	2136-2137	SYM	denotes	=
T25786	2133-2135	SYM	denotes	**
T25785	2131-2132	-COLON-	denotes	;
T25784	2127-2131	CD	denotes	0.05
T25783	2125-2126	SYM	denotes	<
T25782	2123-2124	NN	denotes	p
T25781	2121-2122	SYM	denotes	=
T25780	2119-2120	SYM	denotes	*
T25779	2118-2119	-LRB-	denotes	(
T25778	2115-2117	NN	denotes	GP
T25777	2112-2114	TO	denotes	to
T25776	2103-2111	VB	denotes	compared
T25775	2098-2102	WRB	denotes	when
T25774	2094-2097	NN	denotes	CyA
T25773	2091-2093	CC	denotes	or
T25772	2086-2090	NN	denotes	CAPE
T25771	2084-2085	-COMMA-	denotes	,
T25770	2081-2084	NN	denotes	CHX
T25769	2076-2080	IN	denotes	with
T25768	2066-2075	NN	denotes	treatment
T25767	2056-2065	VB	denotes	following
T25766	2051-2055	NN	denotes	PBMC
T25765	2045-2050	JJ	denotes	human
T25764	2042-2044	IN	denotes	by
T25763	2035-2041	NN	denotes	IL-1RA
T25762	2032-2034	IN	denotes	of
T25761	2021-2031	NN	denotes	production
T25760	2017-2020	DT	denotes	the
T25759	2009-2016	VB	denotes	reduced
T25758	1995-2008	RB	denotes	significantly
T25757	1988-1994	NN	denotes	NFIL-6
T25756	1984-1987	CC	denotes	and
T25755	1979-1983	NN	denotes	NFAT
T25754	1977-1978	-COMMA-	denotes	,
T25753	1973-1977	NN	denotes	NFκB
T25752	1970-1972	IN	denotes	of
T25751	1959-1969	NN	denotes	Inhibition
T25750	1957-1958	-COMMA-	denotes	,
T25749	1956-1957	NN	denotes	C
T25748	1953-1954	-RRB-	denotes	)
T25747	1952-1953	CD	denotes	4
T25746	1950-1951	SYM	denotes	=
T25745	1948-1949	NN	denotes	n
T25744	1946-1947	-COMMA-	denotes	,
T25743	1943-1946	NN	denotes	gel
T25742	1928-1942	JJ	denotes	representative
T25741	1927-1928	-LRB-	denotes	(
T25740	1919-1926	NN	denotes	control
T25739	1906-1918	NN	denotes	housekeeping
T25738	1903-1905	IN	denotes	as
T25737	1898-1902	VB	denotes	used
T25736	1895-1897	VB	denotes	is
T25735	1889-1894	NN	denotes	GAPDH
T25734	1885-1887	NN	denotes	GP
T25733	1882-1884	TO	denotes	to
T25732	1873-1881	VB	denotes	compared
T25731	1869-1872	NN	denotes	CyA
T25730	1866-1868	CC	denotes	or
T25729	1861-1865	NN	denotes	CAPE
T25728	1859-1860	-COMMA-	denotes	,
T25727	1856-1859	NN	denotes	CHX
T25726	1846-1855	VB	denotes	following
T25725	1841-1845	NN	denotes	mRNA
T25724	1834-1840	NN	denotes	IL-1RA
T25723	1824-1833	VB	denotes	decreased
T25722	1821-1823	IN	denotes	in
T25721	1812-1820	VB	denotes	resulted
T25720	1805-1811	NN	denotes	NFIL-6
T25719	1801-1804	CC	denotes	and
T25718	1796-1800	NN	denotes	NFAT
T25717	1794-1795	-COMMA-	denotes	,
T25716	1790-1794	NN	denotes	NFκB
T25715	1787-1789	IN	denotes	of
T25714	1776-1786	NN	denotes	Inhibition
T25713	1774-1775	-COMMA-	denotes	,
T25712	1773-1774	NN	denotes	B
T25711	1770-1771	-RRB-	denotes	)
T25710	1769-1770	CD	denotes	4
T25709	1767-1768	SYM	denotes	=
T25708	1765-1766	NN	denotes	n
T25707	1764-1765	-LRB-	denotes	(
T25706	1760-1763	NN	denotes	SEM
T25705	1758-1759	NN	denotes	±
T25704	1753-1757	JJ	denotes	mean
T25703	1750-1752	IN	denotes	as
T25702	1744-1749	VB	denotes	shown
T25701	1740-1743	VB	denotes	are
T25700	1735-1739	NN	denotes	Data
T25699	1732-1733	-RRB-	denotes	)
T25698	1728-1732	CD	denotes	0.05
T25697	1726-1727	SYM	denotes	<
T25696	1724-1725	NN	denotes	p
T25695	1722-1723	SYM	denotes	=
T25694	1720-1721	SYM	denotes	*
T25693	1719-1720	-LRB-	denotes	(
T25692	1709-1718	VB	denotes	displayed
T25691	1706-1708	VB	denotes	is
T25690	1703-1705	NN	denotes	GP
T25689	1700-1702	TO	denotes	to
T25688	1691-1699	VB	denotes	compared
T25687	1686-1690	WRB	denotes	when
T25686	1675-1685	NN	denotes	inhibition
T25685	1665-1674	VB	denotes	following
T25684	1657-1664	NN	denotes	binding
T25683	1654-1656	IN	denotes	in
T25682	1645-1653	NN	denotes	decrease
T25681	1643-1644	DT	denotes	a
T25680	1633-1642	VB	denotes	depicting
T25679	1631-1632	-COMMA-	denotes	,
T25678	1627-1631	NN	denotes	site
T25677	1618-1626	NN	denotes	NFATP2/3
T25676	1614-1617	DT	denotes	the
T25675	1610-1613	IN	denotes	for
T25674	1602-1609	NN	denotes	summary
T25673	1592-1601	JJ	denotes	graphical
T25672	1590-1591	DT	denotes	a
T25671	1587-1589	IN	denotes	as
T25670	1582-1586	RB	denotes	well
T25669	1579-1581	RB	denotes	as
T25668	1577-1578	-RRB-	denotes	)
T25667	1572-1577	NN	denotes	water
T25666	1570-1571	-COLON-	denotes	:
T25665	1569-1570	CD	denotes	8
T25664	1564-1568	NN	denotes	lane
T25663	1562-1563	-COMMA-	denotes	,
T25662	1557-1562	NN	denotes	oligo
T25661	1548-1556	NN	denotes	NFATP2/3
T25660	1538-1547	JJ	denotes	unlabeled
T25659	1536-1537	CC	denotes	+
T25658	1533-1535	NN	denotes	GP
T25657	1531-1532	-COLON-	denotes	:
T25656	1530-1531	CD	denotes	7
T25655	1525-1529	NN	denotes	lane
T25654	1523-1524	-COMMA-	denotes	,
T25653	1520-1523	NN	denotes	CHX
T25652	1518-1519	SYM	denotes	+
T25651	1515-1517	NN	denotes	GP
T25650	1513-1514	-COLON-	denotes	:
T25649	1512-1513	CD	denotes	6
T25648	1507-1511	NN	denotes	lane
T25647	1505-1506	-COMMA-	denotes	,
T25646	1502-1505	NN	denotes	CyA
T25645	1500-1501	SYM	denotes	+
T25644	1497-1499	NN	denotes	GP
T25643	1495-1496	SYM	denotes	:
T25642	1494-1495	CD	denotes	5
T25641	1489-1493	NN	denotes	lane
T25640	1487-1488	-COMMA-	denotes	,
T25639	1483-1487	NN	denotes	CAPE
T25638	1481-1482	SYM	denotes	+
T25637	1478-1480	NN	denotes	GP
T25636	1476-1477	-COLON-	denotes	:
T25635	1475-1476	CD	denotes	4
T25634	1470-1474	NN	denotes	lane
T25633	1468-1469	-COMMA-	denotes	,
T25632	1463-1468	NN	denotes	oligo
T25631	1454-1462	NN	denotes	NFATP2/3
T25630	1446-1453	VB	denotes	mutated
T25629	1436-1445	JJ	denotes	unlabeled
T25628	1434-1435	CC	denotes	+
T25627	1431-1433	NN	denotes	GP
T25626	1429-1430	-COLON-	denotes	:
T25625	1428-1429	CD	denotes	3
T25624	1423-1427	NN	denotes	lane
T25623	1421-1422	-COMMA-	denotes	,
T25622	1419-1421	NN	denotes	GP
T25621	1417-1418	-COLON-	denotes	:
T25620	1416-1417	CD	denotes	2
T25619	1411-1415	NN	denotes	lane
T25618	1409-1410	-COMMA-	denotes	,
T25617	1402-1409	NN	denotes	control
T25616	1400-1401	-COLON-	denotes	:
T25615	1399-1400	CD	denotes	1
T25614	1394-1398	NN	denotes	lane
T25613	1393-1394	-LRB-	denotes	(
T25612	1379-1392	NN	denotes	autoradiogram
T25611	1364-1378	JJ	denotes	representative
T25610	1362-1363	DT	denotes	A
T25609	1360-1361	-COMMA-	denotes	,
T25608	1359-1360	DT	denotes	A
T25607	1349-1357	NN	denotes	promoter
T25606	1342-1348	NN	denotes	IL-1RA
T25605	1338-1341	DT	denotes	the
T25604	1335-1337	TO	denotes	to
T25603	1327-1334	NN	denotes	binding
T25602	1323-1326	NN	denotes	DNA
T25601	1316-1322	NN	denotes	NFIL-6
T25600	1312-1315	CC	denotes	and
T25599	1307-1311	NN	denotes	NFAT
T25598	1305-1306	-COMMA-	denotes	,
T25597	1301-1305	NN	denotes	NFκB
T25596	1290-1300	JJ	denotes	GP-induced
T25595	1287-1289	IN	denotes	of
T25594	1276-1286	NN	denotes	Inhibition
T25803	2184-2185	-RRB-	denotes	)
T25802	2183-2184	CD	denotes	3
T25801	2181-2182	SYM	denotes	=
T25800	2179-2180	NN	denotes	n
T25799	2178-2179	-LRB-	denotes	(
T25798	2174-2177	NN	denotes	SEM
T25797	2172-2173	NN	denotes	±
T25796	2167-2171	JJ	denotes	mean
T25795	2164-2166	IN	denotes	as
T25794	2158-2163	VB	denotes	shown
T25793	2154-2157	VB	denotes	are
T25792	2149-2153	NN	denotes	Data
T10779	1257-1264	NN	denotes	release
T10778	1250-1256	NN	denotes	IL-1RA
T10777	1240-1249	VB	denotes	decreased
T10776	1238-1239	DT	denotes	a
T10775	1235-1237	TO	denotes	to
T10774	1231-1234	VB	denotes	led
T10773	1224-1230	RB	denotes	mainly
T10772	1220-1223	NN	denotes	CHX
T10771	1216-1219	CC	denotes	and
T10770	1212-1215	NN	denotes	CyA
T10769	1204-1211	IN	denotes	whereas
T10768	1202-1203	-COMMA-	denotes	,
T10767	1189-1202	NN	denotes	transcription
T10766	1185-1188	DT	denotes	the
T10765	1181-1184	CC	denotes	and
T10764	1172-1180	NN	denotes	activity
T10763	1164-1171	NN	denotes	binding
T10762	1160-1163	DT	denotes	the
T10761	1157-1159	IN	denotes	at
T10760	1146-1156	JJ	denotes	pronounced
T10759	1141-1145	RB	denotes	more
T10758	1137-1140	VB	denotes	was
T10757	1132-1136	NN	denotes	CAPE
T10756	1129-1131	IN	denotes	by
T10755	1118-1128	NN	denotes	inhibition
T10754	1113-1117	NN	denotes	NFκB
T10753	1111-1112	-COMMA-	denotes	,
T10752	1101-1111	RB	denotes	Altogether
T10751	1098-1099	-RRB-	denotes	)
T10750	1097-1098	CD	denotes	3
T10749	1095-1096	SYM	denotes	=
T10748	1093-1094	NN	denotes	n
T10747	1092-1093	-LRB-	denotes	(
T10746	1089-1091	NN	denotes	7C
T10745	1084-1088	NNP	denotes	Fig.
T10744	1081-1083	IN	denotes	in
T10743	1075-1080	VB	denotes	shown
T10742	1071-1074	VB	denotes	are
T10741	1068-1070	NN	denotes	GP
T10740	1065-1067	IN	denotes	of
T10739	1063-1064	NN	denotes	h
T10738	1060-1062	CD	denotes	24
T10737	1054-1059	IN	denotes	after
T10736	1047-1053	NN	denotes	levels
T10735	1039-1046	NN	denotes	protein
T10734	1032-1038	NN	denotes	IL-1RA
T10733	1018-1031	VB	denotes	corresponding
T10732	1016-1017	-COMMA-	denotes	,
T10731	1008-1016	NN	denotes	addition
T10730	1005-1007	IN	denotes	In
T10729	1002-1003	-RRB-	denotes	)
T10728	1001-1002	CD	denotes	4
T10727	999-1000	SYM	denotes	=
T10726	997-998	NN	denotes	n
T10725	996-997	-LRB-	denotes	(
T10724	993-995	NN	denotes	7B
T10723	988-992	NNP	denotes	Fig.
T10722	985-987	IN	denotes	in
T10721	975-984	VB	denotes	displayed
T10720	972-974	VB	denotes	is
T10719	968-971	NN	denotes	CHX
T10718	964-967	CC	denotes	and
T10717	960-963	NN	denotes	CyA
T10716	958-959	-COMMA-	denotes	,
T10715	954-958	NN	denotes	CAPE
T10714	949-953	IN	denotes	with
T10713	938-948	NN	denotes	inhibition
T10712	932-937	IN	denotes	after
T10711	927-931	NN	denotes	mRNA
T10710	920-926	NN	denotes	IL-1RA
T10709	917-919	IN	denotes	in
T10708	908-916	NN	denotes	decrease
T10707	906-907	DT	denotes	a
T10706	892-905	VB	denotes	demonstrating
T10705	888-891	NN	denotes	gel
T10704	873-887	JJ	denotes	representative
T10703	871-872	DT	denotes	A
T10702	867-869	NN	denotes	GP
T10701	864-866	IN	denotes	of
T10700	862-863	NN	denotes	h
T10699	859-861	CD	denotes	18
T10698	855-858	CC	denotes	and
T10697	844-854	NN	denotes	inhibition
T10696	842-843	NN	denotes	h
T10695	840-841	CD	denotes	1
T10694	830-839	VB	denotes	following
T10693	821-829	VB	denotes	examined
T10692	817-820	VB	denotes	was
T10691	812-816	NN	denotes	mRNA
T10690	810-811	-COMMA-	denotes	,
T10689	809-810	NN	denotes	h
T10688	806-808	CD	denotes	24
T10687	803-805	IN	denotes	at
T10686	797-802	VB	denotes	found
T10685	793-796	VB	denotes	was
T10684	786-792	NN	denotes	amount
T10683	779-785	NN	denotes	IL-1RA
T10682	771-778	JJ	denotes	highest
T10681	767-770	DT	denotes	the
T10680	759-766	IN	denotes	Because
T10679	756-757	-RRB-	denotes	)
T10678	751-756	VB	denotes	shown
T10677	747-750	RB	denotes	not
T10676	742-746	NN	denotes	data
T10675	741-742	-LRB-	denotes	(
T10674	733-740	JJ	denotes	similar
T10673	728-732	VB	denotes	were
T10672	722-727	NN	denotes	sites
T10671	714-721	NN	denotes	binding
T10670	707-713	NN	denotes	NFIL-6
T10669	703-706	CC	denotes	and
T10668	698-702	NN	denotes	NFκB
T10667	694-697	DT	denotes	the
T10666	690-693	IN	denotes	for
T10665	682-689	NN	denotes	results
T10664	678-681	DT	denotes	The
T10663	675-676	-RRB-	denotes	)
T10662	671-675	NN	denotes	side
T10661	665-670	JJ	denotes	right
T10660	663-664	-COMMA-	denotes	,
T10659	661-663	NNP	denotes	7A
T10658	656-660	NNP	denotes	Fig.
T10657	654-655	-COMMA-	denotes	,
T10656	653-654	CD	denotes	4
T10655	651-652	SYM	denotes	=
T10654	649-650	NN	denotes	n
T10653	648-649	-LRB-	denotes	(
T10652	637-647	VB	denotes	summarized
T10651	625-636	RB	denotes	graphically
T10650	621-624	CC	denotes	and
T10649	619-620	-RRB-	denotes	)
T10648	615-619	NN	denotes	side
T10647	610-614	JJ	denotes	left
T10646	608-609	-COMMA-	denotes	,
T10645	606-608	NNP	denotes	7A
T10644	601-605	NNP	denotes	Fig.
T10643	600-601	-LRB-	denotes	(
T10642	586-599	NN	denotes	autoradiogram
T10641	583-585	DT	denotes	an
T10640	580-582	IN	denotes	in
T10639	574-579	VB	denotes	shown
T10638	562-573	RB	denotes	exemplarily
T10637	559-561	VB	denotes	is
T10636	551-558	NN	denotes	binding
T10635	542-550	NN	denotes	NFATP2/3
T10634	539-541	IN	denotes	in
T10633	529-538	NN	denotes	reduction
T10632	526-528	IN	denotes	of
T10631	519-525	NN	denotes	extent
T10630	515-518	DT	denotes	The
T10629	512-513	-RRB-	denotes	)
T10628	511-512	CD	denotes	7
T10627	506-510	NN	denotes	Fig.
T10626	505-506	-LRB-	denotes	(
T10625	498-504	NN	denotes	levels
T10624	490-497	NN	denotes	protein
T10623	483-489	NN	denotes	IL-1RA
T10622	479-482	CC	denotes	and
T10621	474-478	NN	denotes	mRNA
T10620	467-473	NN	denotes	IL-1RA
T10619	464-466	IN	denotes	of
T10618	454-463	NN	denotes	reduction
T10617	452-453	DT	denotes	a
T10616	448-451	CC	denotes	and
T10615	446-447	-COMMA-	denotes	,
T10614	441-446	NN	denotes	sites
T10613	434-440	NN	denotes	IL-1RA
T10612	430-433	DT	denotes	the
T10611	427-429	TO	denotes	to
T10610	419-426	NN	denotes	factors
T10609	405-418	NN	denotes	transcription
T10608	401-404	DT	denotes	the
T10607	398-400	IN	denotes	of
T10606	389-397	NN	denotes	activity
T10605	381-388	NN	denotes	binding
T10604	366-380	JJ	denotes	down-regulated
T10603	364-365	DT	denotes	a
T10602	361-363	TO	denotes	to
T10601	353-360	VB	denotes	leading
T10600	351-352	-COMMA-	denotes	,
T10599	349-351	NN	denotes	GP
T10598	346-348	IN	denotes	by
T10597	336-345	VB	denotes	overruled
T10596	333-335	VB	denotes	be
T10595	329-332	RB	denotes	not
T10594	323-328	MD	denotes	could
T10593	321-322	-RRB-	denotes	]
T10592	319-321	CD	denotes	36
T10591	318-319	-LRB-	denotes	[
T10590	314-317	NN	denotes	CHX
T10589	310-313	IN	denotes	via
T10588	303-309	NN	denotes	NFIL-6
T10587	299-302	CC	denotes	and
T10586	295-298	NN	denotes	CyA
T10585	291-294	IN	denotes	via
T10584	286-290	NN	denotes	NFAT
T10583	284-285	-COMMA-	denotes	,
T10582	281-284	NN	denotes	CyA
T10581	277-280	CC	denotes	and
T10580	275-276	-RRB-	denotes	]
T10579	273-275	CD	denotes	35
T10578	272-273	-LRB-	denotes	[
T10577	267-271	NN	denotes	CAPE
T10576	263-266	IN	denotes	via
T10575	258-262	NN	denotes	NFκB
T10574	255-257	IN	denotes	of
T10573	244-254	NN	denotes	inhibition
T10572	241-243	DT	denotes	an
T10571	239-240	-COMMA-	denotes	,
T10570	231-239	VB	denotes	expected
T10569	228-230	IN	denotes	As
T10568	224-226	NN	denotes	GP
T10567	221-223	IN	denotes	by
T10566	214-220	NN	denotes	IL-1RA
T10565	211-213	IN	denotes	of
T10564	201-210	NN	denotes	induction
T10563	197-200	DT	denotes	the
T10562	193-196	IN	denotes	for
T10561	184-192	JJ	denotes	relevant
T10560	180-183	VB	denotes	are
T10559	171-179	NN	denotes	promoter
T10558	164-170	NN	denotes	IL-1RA
T10557	160-163	DT	denotes	the
T10556	153-159	IN	denotes	within
T10555	147-152	NN	denotes	sites
T10554	140-146	NN	denotes	factor
T10553	126-139	NN	denotes	transcription
T10552	122-125	DT	denotes	the
T10551	117-121	IN	denotes	that
T10550	105-116	VB	denotes	demonstrate
T10549	102-104	TO	denotes	to
T10548	97-101	VB	denotes	used
T10547	92-96	VB	denotes	were
T10546	81-91	NN	denotes	inhibitors
T10545	65-80	JJ	denotes	Pharmacological
T10544	58-64	NN	denotes	levels
T10543	51-57	NN	denotes	IL-1RA
T10542	43-50	VB	denotes	reduced
T10541	40-42	TO	denotes	to
T10540	36-39	VB	denotes	led
T10539	28-35	NN	denotes	factors
T10538	14-27	NN	denotes	transcription
T10537	11-13	IN	denotes	of
T10536	0-10	NN	denotes	Inhibition
R17312	T25594	T25595	arg1Of	Inhibition,of
R17313	T25597	T25598	arg1Of	NFκB,","
R17314	T25598	T25600	arg1Of	",",and
R17315	T25599	T25598	arg2Of	NFAT,","
R17316	T25601	T25600	arg2Of	NFIL-6,and
R17317	T25603	T25595	arg2Of	binding,of
R17318	T25603	T25596	arg1Of	binding,GP-induced
R17319	T25603	T25597	arg1Of	binding,NFκB
R17320	T25603	T25599	arg1Of	binding,NFAT
R17321	T25603	T25601	arg1Of	binding,NFIL-6
R17322	T25603	T25602	arg1Of	binding,DNA
R17323	T25603	T25604	arg1Of	binding,to
R17324	T25607	T25604	arg2Of	promoter,to
R17325	T25607	T25605	arg1Of	promoter,the
R17326	T25607	T25606	arg1Of	promoter,IL-1RA
R17327	T25612	T25610	arg1Of	autoradiogram,A
R17328	T25612	T25611	arg1Of	autoradiogram,representative
R17329	T25612	T25613	arg1Of	autoradiogram,(
R17330	T25612	T25671	arg1Of	autoradiogram,as
R17331	T25614	T25615	arg1Of	lane,1
R17332	T25614	T25616	arg1Of	lane,:
R17333	T25614	T25657	arg1Of	lane,:
R17334	T25617	T25616	arg2Of	control,:
R17335	T25617	T25618	arg1Of	control,","
R17336	T25617	T25621	arg1Of	control,:
R17337	T25619	T25618	arg2Of	lane,","
R17338	T25619	T25620	arg1Of	lane,2
R17339	T25622	T25621	arg2Of	GP,:
R17340	T25622	T25623	arg1Of	GP,","
R17341	T25622	T25633	arg1Of	GP,","
R17342	T25622	T25636	arg1Of	GP,:
R17343	T25624	T25625	arg1Of	lane,3
R17344	T25624	T25626	arg1Of	lane,:
R17345	T25626	T25623	arg2Of	:,","
R17346	T25627	T25628	arg1Of	GP,+
R17347	T25629	T25628	arg2Of	unlabeled,+
R17348	T25632	T25626	arg2Of	oligo,:
R17349	T25632	T25627	arg1Of	oligo,GP
R17350	T25632	T25629	arg1Of	oligo,unlabeled
R17351	T25632	T25630	arg2Of	oligo,mutated
R17352	T25632	T25631	arg1Of	oligo,NFATP2/3
R17353	T25634	T25633	arg2Of	lane,","
R17354	T25634	T25635	arg1Of	lane,4
R17355	T25639	T25636	arg2Of	CAPE,:
R17356	T25639	T25637	arg1Of	CAPE,GP
R17357	T25639	T25638	arg1Of	CAPE,+
R17358	T25639	T25640	arg1Of	CAPE,","
R17359	T25639	T25647	arg1Of	CAPE,","
R17360	T25639	T25650	arg1Of	CAPE,:
R17361	T25641	T25640	arg2Of	lane,","
R17362	T25641	T25642	arg1Of	lane,5
R17363	T25641	T25643	arg1Of	lane,:
R17364	T25641	T25644	arg1Of	lane,GP
R17365	T25646	T25644	arg2Of	CyA,GP
R17366	T25646	T25645	arg1Of	CyA,+
R17367	T25648	T25647	arg2Of	lane,","
R17368	T25648	T25649	arg1Of	lane,6
R17369	T25653	T25650	arg2Of	CHX,:
R17370	T25653	T25651	arg1Of	CHX,GP
R17371	T25653	T25652	arg1Of	CHX,+
R17372	T25653	T25654	arg1Of	CHX,","
R17373	T25655	T25654	arg2Of	lane,","
R17374	T25655	T25656	arg1Of	lane,7
R17375	T25657	T25613	arg2Of	:,(
R17376	T25657	T25666	arg1Of	:,:
R17377	T25662	T25657	arg2Of	oligo,:
R17378	T25662	T25658	arg1Of	oligo,GP
R17379	T25662	T25659	arg1Of	oligo,+
R17380	T25662	T25660	arg1Of	oligo,unlabeled
R17381	T25662	T25661	arg1Of	oligo,NFATP2/3
R17382	T25662	T25663	arg1Of	oligo,","
R17383	T25664	T25663	arg2Of	lane,","
R17384	T25664	T25665	arg1Of	lane,8
R17385	T25667	T25666	arg2Of	water,:
R17386	T25668	T25613	arg3Of	),(
R17387	T25671	T25669	arg1Of	as,as
R17388	T25671	T25670	arg1Of	as,well
R17389	T25671	T25691	arg1Of	as,is
R17390	T25671	T25692	arg2Of	as,displayed
R17391	T25674	T25671	arg2Of	summary,as
R17392	T25674	T25672	arg1Of	summary,a
R17393	T25674	T25673	arg1Of	summary,graphical
R17394	T25674	T25675	arg1Of	summary,for
R17395	T25678	T25675	arg2Of	site,for
R17396	T25678	T25676	arg1Of	site,the
R17397	T25678	T25677	arg1Of	site,NFATP2/3
R17398	T25678	T25679	arg1Of	site,","
R17399	T25680	T25679	arg2Of	depicting,","
R17400	T25680	T25687	arg1Of	depicting,when
R17401	T25682	T25680	arg2Of	decrease,depicting
R17402	T25682	T25681	arg1Of	decrease,a
R17403	T25682	T25683	arg1Of	decrease,in
R17404	T25684	T25683	arg2Of	binding,in
R17405	T25684	T25685	arg1Of	binding,following
R17406	T25686	T25685	arg2Of	inhibition,following
R17407	T25688	T25687	arg2Of	compared,when
R17408	T25688	T25689	arg1Of	compared,to
R17409	T25690	T25689	arg2Of	GP,to
R17410	T25692	T25608	arg1Of	displayed,A
R17411	T25692	T25609	arg1Of	displayed,","
R17412	T25692	T25691	arg2Of	displayed,is
R17413	T25692	T25693	arg1Of	displayed,(
R17414	T25696	T25693	arg2Of	p,(
R17415	T25696	T25694	arg1Of	p,*
R17416	T25696	T25695	arg1Of	p,=
R17417	T25696	T25697	arg1Of	p,<
R17418	T25696	T25698	arg1Of	p,0.05
R17419	T25699	T25693	arg3Of	),(
R17420	T25700	T25701	arg1Of	Data,are
R17421	T25700	T25702	arg2Of	Data,shown
R17422	T25702	T25701	arg2Of	shown,are
R17423	T25702	T25703	arg1Of	shown,as
R17424	T25706	T25703	arg2Of	SEM,as
R17425	T25706	T25704	arg1Of	SEM,mean
R17426	T25706	T25705	arg1Of	SEM,±
R17427	T25706	T25707	arg1Of	SEM,(
R17428	T25708	T25707	arg2Of	n,(
R17429	T25708	T25709	arg1Of	n,=
R17430	T25708	T25710	arg1Of	n,4
R17431	T25711	T25707	arg3Of	),(
R17432	T25712	T25713	arg1Of	B,","
R17433	T25713	T25717	arg1Of	",",","
R17434	T25714	T25713	arg2Of	Inhibition,","
R17435	T25714	T25715	arg1Of	Inhibition,of
R17436	T25716	T25715	arg2Of	NFκB,of
R17437	T25717	T25719	arg1Of	",",and
R17438	T25718	T25717	arg2Of	NFAT,","
R17439	T25719	T25721	arg1Of	and,resulted
R17440	T25720	T25719	arg2Of	NFIL-6,and
R17441	T25721	T25722	arg1Of	resulted,in
R17442	T25721	T25726	arg1Of	resulted,following
R17443	T25721	T25732	arg1Of	resulted,compared
R17444	T25725	T25722	arg2Of	mRNA,in
R17445	T25725	T25723	arg2Of	mRNA,decreased
R17446	T25725	T25724	arg1Of	mRNA,IL-1RA
R17447	T25727	T25728	arg1Of	CHX,","
R17448	T25728	T25730	arg1Of	",",or
R17449	T25729	T25728	arg2Of	CAPE,","
R17450	T25730	T25726	arg2Of	or,following
R17451	T25731	T25730	arg2Of	CyA,or
R17452	T25733	T25732	arg2Of	to,compared
R17453	T25734	T25733	arg2Of	GP,to
R17454	T25735	T25736	arg1Of	GAPDH,is
R17455	T25735	T25737	arg2Of	GAPDH,used
R17456	T25737	T25736	arg2Of	used,is
R17457	T25737	T25738	arg1Of	used,as
R17458	T25740	T25738	arg2Of	control,as
R17459	T25740	T25739	arg1Of	control,housekeeping
R17460	T25740	T25741	arg1Of	control,(
R17461	T25743	T25741	arg2Of	gel,(
R17462	T25743	T25742	arg1Of	gel,representative
R17463	T25743	T25744	arg1Of	gel,","
R17464	T25745	T25744	arg2Of	n,","
R17465	T25745	T25746	arg1Of	n,=
R17466	T25745	T25747	arg1Of	n,4
R17467	T25748	T25741	arg3Of	),(
R17468	T25749	T25750	arg1Of	C,","
R17469	T25750	T25754	arg1Of	",",","
R17470	T25751	T25750	arg2Of	Inhibition,","
R17471	T25751	T25752	arg1Of	Inhibition,of
R17472	T25753	T25752	arg2Of	NFκB,of
R17473	T25754	T25756	arg1Of	",",and
R17474	T25755	T25754	arg2Of	NFAT,","
R17475	T25756	T25759	arg1Of	and,reduced
R17476	T25756	T25776	arg1Of	and,compared
R17477	T25757	T25756	arg2Of	NFIL-6,and
R17478	T25759	T25758	arg1Of	reduced,significantly
R17479	T25759	T25767	arg1Of	reduced,following
R17480	T25759	T25775	arg1Of	reduced,when
R17481	T25761	T25759	arg2Of	production,reduced
R17482	T25761	T25760	arg1Of	production,the
R17483	T25761	T25762	arg1Of	production,of
R17484	T25761	T25764	arg1Of	production,by
R17485	T25763	T25762	arg2Of	IL-1RA,of
R17486	T25766	T25764	arg2Of	PBMC,by
R17487	T25766	T25765	arg1Of	PBMC,human
R17488	T25768	T25767	arg2Of	treatment,following
R17489	T25768	T25769	arg1Of	treatment,with
R17490	T25770	T25771	arg1Of	CHX,","
R17491	T25771	T25773	arg1Of	",",or
R17492	T25772	T25771	arg2Of	CAPE,","
R17493	T25773	T25769	arg2Of	or,with
R17494	T25774	T25773	arg2Of	CyA,or
R17495	T25776	T25775	arg2Of	compared,when
R17496	T25776	T25777	arg1Of	compared,to
R17497	T25778	T25777	arg2Of	GP,to
R17498	T25778	T25779	arg1Of	GP,(
R17499	T25784	T25779	arg2Of	0.05,(
R17500	T25784	T25780	arg1Of	0.05,*
R17501	T25784	T25781	arg1Of	0.05,=
R17502	T25784	T25782	arg1Of	0.05,p
R17503	T25784	T25783	arg1Of	0.05,<
R17504	T25784	T25785	arg1Of	0.05,;
R17505	T25784	T25790	arg1Of	0.05,0.01
R17506	T25788	T25785	arg2Of	p,;
R17507	T25788	T25786	arg1Of	p,**
R17508	T25788	T25787	arg1Of	p,=
R17509	T25788	T25789	arg1Of	p,<
R17510	T25791	T25779	arg3Of	),(
R17511	T25792	T25793	arg1Of	Data,are
R17512	T25792	T25794	arg2Of	Data,shown
R17513	T25794	T25793	arg2Of	shown,are
R17514	T25794	T25795	arg1Of	shown,as
R17515	T25798	T25795	arg2Of	SEM,as
R17516	T25798	T25796	arg1Of	SEM,mean
R17517	T25798	T25797	arg1Of	SEM,±
R17518	T25798	T25799	arg1Of	SEM,(
R17519	T25800	T25799	arg2Of	n,(
R17520	T25800	T25801	arg1Of	n,=
R17521	T25800	T25802	arg1Of	n,3
R17522	T25803	T25799	arg3Of	),(
R6858	T10536	T10537	arg1Of	Inhibition,of
R6859	T10536	T10540	arg1Of	Inhibition,led
R6860	T10539	T10537	arg2Of	factors,of
R6861	T10539	T10538	arg1Of	factors,transcription
R6862	T10540	T10541	arg1Of	led,to
R6863	T10544	T10541	arg2Of	levels,to
R6864	T10544	T10542	arg2Of	levels,reduced
R6865	T10544	T10543	arg1Of	levels,IL-1RA
R6866	T10546	T10545	arg1Of	inhibitors,Pharmacological
R6867	T10546	T10547	arg1Of	inhibitors,were
R6868	T10546	T10548	arg2Of	inhibitors,used
R6869	T10546	T10550	arg1Of	inhibitors,demonstrate
R6870	T10548	T10547	arg2Of	used,were
R6871	T10550	T10548	arg3Of	demonstrate,used
R6872	T10550	T10549	arg1Of	demonstrate,to
R6873	T10555	T10552	arg1Of	sites,the
R6874	T10555	T10553	arg1Of	sites,transcription
R6875	T10555	T10554	arg1Of	sites,factor
R6876	T10555	T10556	arg1Of	sites,within
R6877	T10555	T10560	arg1Of	sites,are
R6878	T10555	T10561	arg1Of	sites,relevant
R6879	T10559	T10556	arg2Of	promoter,within
R6880	T10559	T10557	arg1Of	promoter,the
R6881	T10559	T10558	arg1Of	promoter,IL-1RA
R6882	T10560	T10550	arg2Of	are,demonstrate
R6883	T10560	T10551	arg1Of	are,that
R6884	T10561	T10560	arg2Of	relevant,are
R6885	T10561	T10562	arg1Of	relevant,for
R6886	T10564	T10562	arg2Of	induction,for
R6887	T10564	T10563	arg1Of	induction,the
R6888	T10564	T10565	arg1Of	induction,of
R6889	T10564	T10567	arg1Of	induction,by
R6890	T10566	T10565	arg2Of	IL-1RA,of
R6891	T10568	T10567	arg2Of	GP,by
R6892	T10570	T10569	arg2Of	expected,As
R6893	T10573	T10572	arg1Of	inhibition,an
R6894	T10573	T10574	arg1Of	inhibition,of
R6895	T10573	T10576	arg1Of	inhibition,via
R6896	T10573	T10589	arg1Of	inhibition,via
R6897	T10573	T10594	arg1Of	inhibition,could
R6898	T10573	T10596	arg1Of	inhibition,be
R6899	T10573	T10597	arg2Of	inhibition,overruled
R6900	T10575	T10574	arg2Of	NFκB,of
R6901	T10577	T10578	arg1Of	CAPE,[
R6902	T10577	T10581	arg1Of	CAPE,and
R6903	T10579	T10578	arg2Of	35,[
R6904	T10580	T10578	arg3Of	],[
R6905	T10581	T10576	arg2Of	and,via
R6906	T10582	T10583	arg1Of	CyA,","
R6907	T10583	T10581	arg2Of	",",and
R6908	T10583	T10585	arg1Of	",",via
R6909	T10584	T10583	arg2Of	NFAT,","
R6910	T10586	T10587	arg1Of	CyA,and
R6911	T10587	T10585	arg2Of	and,via
R6912	T10588	T10587	arg2Of	NFIL-6,and
R6913	T10590	T10589	arg2Of	CHX,via
R6914	T10590	T10591	arg1Of	CHX,[
R6915	T10592	T10591	arg2Of	36,[
R6916	T10593	T10591	arg3Of	],[
R6917	T10597	T10569	arg1Of	overruled,As
R6918	T10597	T10571	arg1Of	overruled,","
R6919	T10597	T10594	arg2Of	overruled,could
R6920	T10597	T10595	arg1Of	overruled,not
R6921	T10597	T10596	arg2Of	overruled,be
R6922	T10597	T10600	arg1Of	overruled,","
R6923	T10597	T10601	modOf	overruled,leading
R6924	T10599	T10597	arg1Of	GP,overruled
R6925	T10599	T10598	arg2Of	GP,by
R6926	T10601	T10602	arg1Of	leading,to
R6927	T10606	T10603	arg1Of	activity,a
R6928	T10606	T10604	arg1Of	activity,down-regulated
R6929	T10606	T10605	arg1Of	activity,binding
R6930	T10606	T10607	arg1Of	activity,of
R6931	T10606	T10611	arg1Of	activity,to
R6932	T10606	T10616	arg1Of	activity,and
R6933	T10610	T10607	arg2Of	factors,of
R6934	T10610	T10608	arg1Of	factors,the
R6935	T10610	T10609	arg1Of	factors,transcription
R6936	T10614	T10611	arg2Of	sites,to
R6937	T10614	T10612	arg1Of	sites,the
R6938	T10614	T10613	arg1Of	sites,IL-1RA
R6939	T10616	T10602	arg2Of	and,to
R6940	T10616	T10615	arg1Of	and,","
R6941	T10618	T10616	arg2Of	reduction,and
R6942	T10618	T10617	arg1Of	reduction,a
R6943	T10618	T10619	arg1Of	reduction,of
R6944	T10621	T10620	arg1Of	mRNA,IL-1RA
R6945	T10621	T10622	arg1Of	mRNA,and
R6946	T10622	T10619	arg2Of	and,of
R6947	T10625	T10622	arg2Of	levels,and
R6948	T10625	T10623	arg1Of	levels,IL-1RA
R6949	T10625	T10624	arg1Of	levels,protein
R6950	T10625	T10626	arg1Of	levels,(
R6951	T10627	T10626	arg2Of	Fig.,(
R6952	T10627	T10628	arg1Of	Fig.,7
R6953	T10629	T10626	arg3Of	),(
R6954	T10631	T10630	arg1Of	extent,The
R6955	T10631	T10632	arg1Of	extent,of
R6956	T10631	T10634	arg1Of	extent,in
R6957	T10631	T10637	arg1Of	extent,is
R6958	T10631	T10639	arg2Of	extent,shown
R6959	T10631	T10652	arg2Of	extent,summarized
R6960	T10633	T10632	arg2Of	reduction,of
R6961	T10636	T10634	arg2Of	binding,in
R6962	T10636	T10635	arg1Of	binding,NFATP2/3
R6963	T10639	T10640	arg1Of	shown,in
R6964	T10639	T10643	arg1Of	shown,(
R6965	T10639	T10650	arg1Of	shown,and
R6966	T10642	T10640	arg2Of	autoradiogram,in
R6967	T10642	T10641	arg1Of	autoradiogram,an
R6968	T10645	T10643	arg2Of	7A,(
R6969	T10645	T10644	arg1Of	7A,Fig.
R6970	T10645	T10646	arg1Of	7A,","
R6971	T10648	T10646	arg2Of	side,","
R6972	T10648	T10647	arg1Of	side,left
R6973	T10649	T10643	arg3Of	),(
R6974	T10650	T10637	arg2Of	and,is
R6975	T10650	T10638	arg1Of	and,exemplarily
R6976	T10652	T10650	arg2Of	summarized,and
R6977	T10652	T10651	arg1Of	summarized,graphically
R6978	T10652	T10653	arg1Of	summarized,(
R6979	T10654	T10653	arg2Of	n,(
R6980	T10654	T10655	arg1Of	n,=
R6981	T10654	T10657	arg1Of	n,","
R6982	T10654	T10660	arg1Of	n,","
R6983	T10655	T10656	arg1Of	=,4
R6984	T10659	T10657	arg2Of	7A,","
R6985	T10659	T10658	arg1Of	7A,Fig.
R6986	T10662	T10660	arg2Of	side,","
R6987	T10662	T10661	arg1Of	side,right
R6988	T10663	T10653	arg3Of	),(
R6989	T10665	T10664	arg1Of	results,The
R6990	T10665	T10666	arg1Of	results,for
R6991	T10665	T10673	arg1Of	results,were
R6992	T10665	T10674	arg1Of	results,similar
R6993	T10668	T10669	arg1Of	NFκB,and
R6994	T10670	T10669	arg2Of	NFIL-6,and
R6995	T10672	T10666	arg2Of	sites,for
R6996	T10672	T10667	arg1Of	sites,the
R6997	T10672	T10668	arg1Of	sites,NFκB
R6998	T10672	T10670	arg1Of	sites,NFIL-6
R6999	T10672	T10671	arg1Of	sites,binding
R7000	T10674	T10673	arg2Of	similar,were
R7001	T10674	T10675	arg1Of	similar,(
R7002	T10676	T10675	arg2Of	data,(
R7003	T10676	T10678	arg2Of	data,shown
R7004	T10678	T10677	arg1Of	shown,not
R7005	T10679	T10675	arg3Of	),(
R7006	T10684	T10681	arg1Of	amount,the
R7007	T10684	T10682	arg1Of	amount,highest
R7008	T10684	T10683	arg1Of	amount,IL-1RA
R7009	T10684	T10685	arg1Of	amount,was
R7010	T10684	T10686	arg2Of	amount,found
R7011	T10686	T10680	arg2Of	found,Because
R7012	T10686	T10685	arg2Of	found,was
R7013	T10686	T10687	arg1Of	found,at
R7014	T10689	T10687	arg2Of	h,at
R7015	T10689	T10688	arg1Of	h,24
R7016	T10691	T10692	arg1Of	mRNA,was
R7017	T10691	T10693	arg2Of	mRNA,examined
R7018	T10693	T10680	arg1Of	examined,Because
R7019	T10693	T10690	arg1Of	examined,","
R7020	T10693	T10692	arg2Of	examined,was
R7021	T10693	T10694	arg1Of	examined,following
R7022	T10697	T10695	arg1Of	inhibition,1
R7023	T10697	T10696	arg1Of	inhibition,h
R7024	T10697	T10698	arg1Of	inhibition,and
R7025	T10698	T10694	arg2Of	and,following
R7026	T10700	T10698	arg2Of	h,and
R7027	T10700	T10699	arg1Of	h,18
R7028	T10700	T10701	arg1Of	h,of
R7029	T10702	T10701	arg2Of	GP,of
R7030	T10705	T10703	arg1Of	gel,A
R7031	T10705	T10704	arg1Of	gel,representative
R7032	T10705	T10706	arg1Of	gel,demonstrating
R7033	T10705	T10720	arg1Of	gel,is
R7034	T10705	T10721	arg2Of	gel,displayed
R7035	T10708	T10706	arg2Of	decrease,demonstrating
R7036	T10708	T10707	arg1Of	decrease,a
R7037	T10708	T10709	arg1Of	decrease,in
R7038	T10708	T10712	arg1Of	decrease,after
R7039	T10708	T10714	arg1Of	decrease,with
R7040	T10711	T10709	arg2Of	mRNA,in
R7041	T10711	T10710	arg1Of	mRNA,IL-1RA
R7042	T10713	T10712	arg2Of	inhibition,after
R7043	T10715	T10716	arg1Of	CAPE,","
R7044	T10716	T10718	arg1Of	",",and
R7045	T10717	T10716	arg2Of	CyA,","
R7046	T10718	T10714	arg2Of	and,with
R7047	T10719	T10718	arg2Of	CHX,and
R7048	T10721	T10720	arg2Of	displayed,is
R7049	T10721	T10722	arg1Of	displayed,in
R7050	T10724	T10722	arg2Of	7B,in
R7051	T10724	T10723	arg1Of	7B,Fig.
R7052	T10724	T10725	arg1Of	7B,(
R7053	T10726	T10725	arg2Of	n,(
R7054	T10726	T10727	arg1Of	n,=
R7055	T10726	T10728	arg1Of	n,4
R7056	T10729	T10725	arg3Of	),(
R7057	T10731	T10730	arg2Of	addition,In
R7058	T10736	T10733	arg1Of	levels,corresponding
R7059	T10736	T10734	arg1Of	levels,IL-1RA
R7060	T10736	T10735	arg1Of	levels,protein
R7061	T10736	T10737	arg1Of	levels,after
R7062	T10736	T10742	arg1Of	levels,are
R7063	T10736	T10743	arg2Of	levels,shown
R7064	T10739	T10737	arg2Of	h,after
R7065	T10739	T10738	arg1Of	h,24
R7066	T10739	T10740	arg1Of	h,of
R7067	T10741	T10740	arg2Of	GP,of
R7068	T10743	T10730	arg1Of	shown,In
R7069	T10743	T10732	arg1Of	shown,","
R7070	T10743	T10742	arg2Of	shown,are
R7071	T10743	T10744	arg1Of	shown,in
R7072	T10746	T10744	arg2Of	7C,in
R7073	T10746	T10745	arg1Of	7C,Fig.
R7074	T10746	T10747	arg1Of	7C,(
R7075	T10748	T10747	arg2Of	n,(
R7076	T10748	T10749	arg1Of	n,=
R7077	T10748	T10750	arg1Of	n,3
R7078	T10751	T10747	arg3Of	),(
R7079	T10755	T10754	arg1Of	inhibition,NFκB
R7080	T10755	T10756	arg1Of	inhibition,by
R7081	T10755	T10758	arg1Of	inhibition,was
R7082	T10755	T10760	arg1Of	inhibition,pronounced
R7083	T10757	T10756	arg2Of	CAPE,by
R7084	T10758	T10752	arg1Of	was,Altogether
R7085	T10758	T10753	arg1Of	was,","
R7086	T10758	T10761	arg1Of	was,at
R7087	T10758	T10769	arg1Of	was,whereas
R7088	T10760	T10758	arg2Of	pronounced,was
R7089	T10760	T10759	arg1Of	pronounced,more
R7090	T10764	T10762	arg1Of	activity,the
R7091	T10764	T10763	arg1Of	activity,binding
R7092	T10764	T10765	arg1Of	activity,and
R7093	T10765	T10761	arg2Of	and,at
R7094	T10767	T10765	arg2Of	transcription,and
R7095	T10767	T10766	arg1Of	transcription,the
R7096	T10769	T10768	arg1Of	whereas,","
R7097	T10770	T10771	arg1Of	CyA,and
R7098	T10771	T10774	arg1Of	and,led
R7099	T10772	T10771	arg2Of	CHX,and
R7100	T10774	T10769	arg2Of	led,whereas
R7101	T10774	T10773	arg1Of	led,mainly
R7102	T10774	T10775	arg1Of	led,to
R7103	T10779	T10775	arg2Of	release,to
R7104	T10779	T10776	arg1Of	release,a
R7105	T10779	T10777	arg2Of	release,decreased
R7106	T10779	T10778	arg1Of	release,IL-1RA

bionlp-st-ge-2016-test-proteins

Id	Subject	Object	Predicate	Lexical cue
T25543	2035-2041	Protein	denotes	IL-1RA
T25542	1988-1994	Protein	denotes	NFIL-6
T25541	1979-1983	Protein	denotes	NFAT
T25540	1889-1894	Protein	denotes	GAPDH
T25539	1834-1840	Protein	denotes	IL-1RA
T25538	1805-1811	Protein	denotes	NFIL-6
T25537	1796-1800	Protein	denotes	NFAT
T25536	1342-1348	Protein	denotes	IL-1RA
T25535	1316-1322	Protein	denotes	NFIL-6
T25534	1307-1311	Protein	denotes	NFAT
T10514	1250-1256	Protein	denotes	IL-1RA
T10513	1032-1038	Protein	denotes	IL-1RA
T10512	920-926	Protein	denotes	IL-1RA
T10511	779-785	Protein	denotes	IL-1RA
T10510	483-489	Protein	denotes	IL-1RA
T10509	467-473	Protein	denotes	IL-1RA
T10508	434-440	Protein	denotes	IL-1RA
T10507	303-309	Protein	denotes	NFIL-6
T10506	286-290	Protein	denotes	NFAT
T10505	214-220	Protein	denotes	IL-1RA
T10504	164-170	Protein	denotes	IL-1RA
T10503	51-57	Protein	denotes	IL-1RA

bionlp-st-ge-2016-uniprot

Id	Subject	Object	Predicate	Lexical cue
T10789	1250-1256	http://www.uniprot.org/uniprot/P18510	denotes	IL-1RA
T10788	1032-1038	http://www.uniprot.org/uniprot/P18510	denotes	IL-1RA
T10787	920-926	http://www.uniprot.org/uniprot/P18510	denotes	IL-1RA
T10786	779-785	http://www.uniprot.org/uniprot/P18510	denotes	IL-1RA
T10785	483-489	http://www.uniprot.org/uniprot/P18510	denotes	IL-1RA
T10784	467-473	http://www.uniprot.org/uniprot/P18510	denotes	IL-1RA
T10783	434-440	http://www.uniprot.org/uniprot/P18510	denotes	IL-1RA
T10782	214-220	http://www.uniprot.org/uniprot/P18510	denotes	IL-1RA
T10781	164-170	http://www.uniprot.org/uniprot/P18510	denotes	IL-1RA
T10780	51-57	http://www.uniprot.org/uniprot/P18510	denotes	IL-1RA
T25804	1342-1348	http://www.uniprot.org/uniprot/P18510	denotes	IL-1RA
T25805	1834-1840	http://www.uniprot.org/uniprot/P18510	denotes	IL-1RA
T25807	1889-1894	http://www.uniprot.org/uniprot/P04406	denotes	GAPDH
T25806	2035-2041	http://www.uniprot.org/uniprot/P18510	denotes	IL-1RA

GO-BP

Id	Subject	Object	Predicate	Lexical cue
T10460	389-426	http://purl.obolibrary.org/obo/GO_0051090	denotes	activity of the transcription factors
T10459	389-426	http://purl.obolibrary.org/obo/GO_0006352	denotes	activity of the transcription factors
T10458	389-426	http://purl.obolibrary.org/obo/GO_0034246	denotes	activity of the transcription factors
T10457	389-426	http://purl.obolibrary.org/obo/GO_0003700	denotes	activity of the transcription factors
T10456	389-426	http://purl.obolibrary.org/obo/GO_0001071	denotes	activity of the transcription factors
T10455	389-426	http://purl.obolibrary.org/obo/GO_0001070	denotes	activity of the transcription factors
T10454	389-426	http://purl.obolibrary.org/obo/GO_0000988	denotes	activity of the transcription factors
T10453	389-426	http://purl.obolibrary.org/obo/GO_0051091	denotes	activity of the transcription factors
T10452	1189-1202	http://purl.obolibrary.org/obo/GO_0006351	denotes	transcription
T10451	405-418	http://purl.obolibrary.org/obo/GO_0006351	denotes	transcription
T10450	126-139	http://purl.obolibrary.org/obo/GO_0006351	denotes	transcription
T10449	14-27	http://purl.obolibrary.org/obo/GO_0006351	denotes	transcription
T10448	0-35	http://purl.obolibrary.org/obo/GO_0032792	denotes	Inhibition of transcription factors
T10447	389-426	http://purl.obolibrary.org/obo/GO_0043433	denotes	activity of the transcription factors
T10446	0-35	http://purl.obolibrary.org/obo/GO_0043433	denotes	Inhibition of transcription factors
T10445	0-35	http://purl.obolibrary.org/obo/GO_1901484	denotes	Inhibition of transcription factors

GO-MF

Id	Subject	Object	Predicate	Lexical cue
T25547	1327-1344	http://purl.obolibrary.org/obo/GO_0019955	denotes	binding to the IL
T25546	1657-1664	http://purl.obolibrary.org/obo/GO_0005488	denotes	binding
T25545	1327-1334	http://purl.obolibrary.org/obo/GO_0005488	denotes	binding
T25544	1323-1334	http://purl.obolibrary.org/obo/GO_0003677	denotes	DNA binding
T10523	389-426	http://purl.obolibrary.org/obo/GO_0034246	denotes	activity of the transcription factors
T10522	389-426	http://purl.obolibrary.org/obo/GO_0003700	denotes	activity of the transcription factors
T10521	389-426	http://purl.obolibrary.org/obo/GO_0001071	denotes	activity of the transcription factors
T10520	389-426	http://purl.obolibrary.org/obo/GO_0001070	denotes	activity of the transcription factors
T10519	389-426	http://purl.obolibrary.org/obo/GO_0000988	denotes	activity of the transcription factors
T10518	1164-1171	http://purl.obolibrary.org/obo/GO_0005488	denotes	binding
T10517	714-721	http://purl.obolibrary.org/obo/GO_0005488	denotes	binding
T10516	551-558	http://purl.obolibrary.org/obo/GO_0005488	denotes	binding
T10515	381-388	http://purl.obolibrary.org/obo/GO_0005488	denotes	binding

sentences

Id	Subject	Object	Predicate	Lexical cue
T25506	2149-2186	Sentence	denotes	Data are shown as mean ± SEM (n = 3).
T25505	1956-2148	Sentence	denotes	C, Inhibition of NFκB, NFAT and NFIL-6 significantly reduced the production of IL-1RA by human PBMC following treatment with CHX, CAPE or CyA when compared to GP (* = p < 0.05; ** = p < 0.01).
T25504	1889-1955	Sentence	denotes	GAPDH is used as housekeeping control (representative gel, n = 4).
T25503	1773-1888	Sentence	denotes	B, Inhibition of NFκB, NFAT and NFIL-6 resulted in decreased IL-1RA mRNA following CHX, CAPE or CyA compared to GP.
T25502	1735-1772	Sentence	denotes	Data are shown as mean ± SEM (n = 4).
T25501	1359-1734	Sentence	denotes	A, A representative autoradiogram (lane 1: control, lane 2: GP, lane 3: GP + unlabeled mutated NFATP2/3 oligo, lane 4: GP + CAPE, lane 5: GP + CyA, lane 6: GP + CHX, lane 7: GP + unlabeled NFATP2/3 oligo, lane 8: water) as well as a graphical summary for the NFATP2/3 site, depicting a decrease in binding following inhibition when compared to GP is displayed (* = p < 0.05).
T25500	1276-1358	Sentence	denotes	Inhibition of GP-induced NFκB, NFAT and NFIL-6 DNA binding to the IL-1RA promoter.
T10444	1101-1265	Sentence	denotes	Altogether, NFκB inhibition by CAPE was more pronounced at the binding activity and the transcription, whereas CyA and CHX mainly led to a decreased IL-1RA release.
T10443	1005-1100	Sentence	denotes	In addition, corresponding IL-1RA protein levels after 24 h of GP are shown in Fig. 7C (n = 3).
T10442	871-1004	Sentence	denotes	A representative gel demonstrating a decrease in IL-1RA mRNA after inhibition with CAPE, CyA and CHX is displayed in Fig. 7B (n = 4).
T10441	759-870	Sentence	denotes	Because the highest IL-1RA amount was found at 24 h, mRNA was examined following 1 h inhibition and 18 h of GP.
T10440	678-758	Sentence	denotes	The results for the NFκB and NFIL-6 binding sites were similar (data not shown).
T10439	515-677	Sentence	denotes	The extent of reduction in NFATP2/3 binding is exemplarily shown in an autoradiogram (Fig. 7A, left side) and graphically summarized (n = 4, Fig. 7A, right side).
T10438	228-514	Sentence	denotes	As expected, an inhibition of NFκB via CAPE [35] and CyA, NFAT via CyA and NFIL-6 via CHX [36] could not be overruled by GP, leading to a down-regulated binding activity of the transcription factors to the IL-1RA sites, and a reduction of IL-1RA mRNA and IL-1RA protein levels (Fig. 7).
T10437	65-227	Sentence	denotes	Pharmacological inhibitors were used to demonstrate that the transcription factor sites within the IL-1RA promoter are relevant for the induction of IL-1RA by GP.
T10436	0-64	Sentence	denotes	Inhibition of transcription factors led to reduced IL-1RA levels
T161	0-64	Sentence	denotes	Inhibition of transcription factors led to reduced IL-1RA levels
T162	65-227	Sentence	denotes	Pharmacological inhibitors were used to demonstrate that the transcription factor sites within the IL-1RA promoter are relevant for the induction of IL-1RA by GP.
T163	228-514	Sentence	denotes	As expected, an inhibition of NFκB via CAPE [35] and CyA, NFAT via CyA and NFIL-6 via CHX [36] could not be overruled by GP, leading to a down-regulated binding activity of the transcription factors to the IL-1RA sites, and a reduction of IL-1RA mRNA and IL-1RA protein levels (Fig. 7).
T164	515-677	Sentence	denotes	The extent of reduction in NFATP2/3 binding is exemplarily shown in an autoradiogram (Fig. 7A, left side) and graphically summarized (n = 4, Fig. 7A, right side).
T165	678-758	Sentence	denotes	The results for the NFκB and NFIL-6 binding sites were similar (data not shown).
T166	759-870	Sentence	denotes	Because the highest IL-1RA amount was found at 24 h, mRNA was examined following 1 h inhibition and 18 h of GP.
T167	871-1004	Sentence	denotes	A representative gel demonstrating a decrease in IL-1RA mRNA after inhibition with CAPE, CyA and CHX is displayed in Fig. 7B (n = 4).
T168	1005-1100	Sentence	denotes	In addition, corresponding IL-1RA protein levels after 24 h of GP are shown in Fig. 7C (n = 3).
T169	1101-1265	Sentence	denotes	Altogether, NFκB inhibition by CAPE was more pronounced at the binding activity and the transcription, whereas CyA and CHX mainly led to a decreased IL-1RA release.
T170	1266-1358	Sentence	denotes	Figure 7 Inhibition of GP-induced NFκB, NFAT and NFIL-6 DNA binding to the IL-1RA promoter.
T171	1359-1734	Sentence	denotes	A, A representative autoradiogram (lane 1: control, lane 2: GP, lane 3: GP + unlabeled mutated NFATP2/3 oligo, lane 4: GP + CAPE, lane 5: GP + CyA, lane 6: GP + CHX, lane 7: GP + unlabeled NFATP2/3 oligo, lane 8: water) as well as a graphical summary for the NFATP2/3 site, depicting a decrease in binding following inhibition when compared to GP is displayed (* = p < 0.05).
T172	1735-1772	Sentence	denotes	Data are shown as mean ± SEM (n = 4).
T173	1773-1888	Sentence	denotes	B, Inhibition of NFκB, NFAT and NFIL-6 resulted in decreased IL-1RA mRNA following CHX, CAPE or CyA compared to GP.
T174	1889-1955	Sentence	denotes	GAPDH is used as housekeeping control (representative gel, n = 4).
T175	1956-2148	Sentence	denotes	C, Inhibition of NFκB, NFAT and NFIL-6 significantly reduced the production of IL-1RA by human PBMC following treatment with CHX, CAPE or CyA when compared to GP (* = p < 0.05; ** = p < 0.01).
T176	2149-2186	Sentence	denotes	Data are shown as mean ± SEM (n = 3).

simple1

Id	Subject	Object	Predicate	Lexical cue
T25593	2035-2041	Protein	denotes	IL-1RA
T25592	1988-1994	Protein	denotes	NFIL-6
T25591	1979-1983	Protein	denotes	NFAT
T25590	1889-1894	Protein	denotes	GAPDH
T25589	1834-1840	Protein	denotes	IL-1RA
T25588	1805-1811	Protein	denotes	NFIL-6
T25587	1796-1800	Protein	denotes	NFAT
T25586	1342-1348	Protein	denotes	IL-1RA
T25585	1316-1322	Protein	denotes	NFIL-6
T25584	1307-1311	Protein	denotes	NFAT
T10535	1250-1256	Protein	denotes	IL-1RA
T10534	1032-1038	Protein	denotes	IL-1RA
T10533	920-926	Protein	denotes	IL-1RA
T10532	779-785	Protein	denotes	IL-1RA
T10531	483-489	Protein	denotes	IL-1RA
T10530	467-473	Protein	denotes	IL-1RA
T10529	434-440	Protein	denotes	IL-1RA
T10528	303-309	Protein	denotes	NFIL-6
T10527	286-290	Protein	denotes	NFAT
T10526	214-220	Protein	denotes	IL-1RA
T10525	164-170	Protein	denotes	IL-1RA
T10524	51-57	Protein	denotes	IL-1RA

BioNLP16_DUT

Id	Subject	Object	Predicate	Lexical cue
T26152	2009-2016	Negative_regulation	denotes	reduced
T26151	2021-2031	Gene_expression	denotes	production
T26150	1959-1969	Negative_regulation	denotes	Inhibition
T26149	1824-1833	Negative_regulation	denotes	decreased
T26148	1812-1820	Positive_regulation	denotes	resulted
T26147	1276-1286	Negative_regulation	denotes	Inhibition
T26146	1327-1334	Binding	denotes	binding
T26145	1988-1994	Protein	denotes	NFIL-6
T26144	1979-1983	Protein	denotes	NFAT
T26143	2035-2041	Protein	denotes	IL-1RA
T26142	1889-1894	Protein	denotes	GAPDH
T26141	1834-1840	Protein	denotes	IL-1RA
T26140	1805-1811	Protein	denotes	NFIL-6
T26139	1796-1800	Protein	denotes	NFAT
T26138	1342-1348	Protein	denotes	IL-1RA
T26137	1316-1322	Protein	denotes	NFIL-6
T26136	1307-1311	Protein	denotes	NFAT
T11196	1257-1264	Localization	denotes	release
T11195	1240-1249	Negative_regulation	denotes	decreased
T11194	908-916	Negative_regulation	denotes	decrease
T11193	454-463	Negative_regulation	denotes	reduction
T11192	184-192	Positive_regulation	denotes	relevant
T11191	201-210	Positive_regulation	denotes	induction
T11190	43-50	Negative_regulation	denotes	reduced
T11189	1250-1256	Protein	denotes	IL-1RA
T11188	1032-1038	Protein	denotes	IL-1RA
T11187	920-926	Protein	denotes	IL-1RA
T11186	779-785	Protein	denotes	IL-1RA
T11185	483-489	Protein	denotes	IL-1RA
T11184	467-473	Protein	denotes	IL-1RA
T11183	434-440	Protein	denotes	IL-1RA
T11182	303-309	Protein	denotes	NFIL-6
T11181	286-290	Protein	denotes	NFAT
T11180	214-220	Protein	denotes	IL-1RA
T11179	164-170	Protein	denotes	IL-1RA
T11178	51-57	Protein	denotes	IL-1RA
R7411	T11178	T11190	themeOf	IL-1RA,reduced
R7412	T11180	T11191	themeOf	IL-1RA,induction
R7413	T11184	T11193	themeOf	IL-1RA,reduction
R7414	T11185	T11193	themeOf	IL-1RA,reduction
R7415	T11187	T11194	themeOf	IL-1RA,decrease
R7416	T11189	T11196	themeOf	IL-1RA,release
R7417	T11191	T11192	themeOf	induction,relevant
R7418	T11196	T11195	themeOf	release,decreased
R17809	T26136	T26146	themeOf	NFAT,binding
R17811	T26137	T26146	themeOf	NFIL-6,binding
R17813	T26138	T26146	themeOf	IL-1RA,binding
R17810	T26136	T26147	themeOf	NFAT,Inhibition
R17812	T26137	T26147	themeOf	NFIL-6,Inhibition
R17814	T26138	T26146	themeOf	IL-1RA,binding
R17815	T26139	T26148	themeOf	NFAT,resulted
R17816	T26140	T26148	themeOf	NFIL-6,resulted
R17817	T26141	T26148	themeOf	IL-1RA,resulted
R17818	T26141	T26149	themeOf	IL-1RA,decreased
R17819	T26143	T26151	themeOf	IL-1RA,production
R17820	T26144	T26150	themeOf	NFAT,Inhibition
R17821	T26145	T26150	themeOf	NFIL-6,Inhibition
R17822	T26151	T26152	themeOf	production,reduced

BioNLP16_Messiy

Id	Subject	Object	Predicate	Lexical cue
T10808	1240-1249	Negative_regulation	denotes	decreased
T10807	1257-1264	Localization	denotes	release
T10806	908-916	Negative_regulation	denotes	decrease
T10805	454-463	Negative_regulation	denotes	reduction
T10804	201-210	Positive_regulation	denotes	induction
T10803	43-50	Negative_regulation	denotes	reduced
T10802	36-39	Positive_regulation	denotes	led
T10801	1250-1256	Protein	denotes	IL-1RA
T10800	1032-1038	Protein	denotes	IL-1RA
T10799	920-926	Protein	denotes	IL-1RA
T10798	779-785	Protein	denotes	IL-1RA
T10797	483-489	Protein	denotes	IL-1RA
T10796	467-473	Protein	denotes	IL-1RA
T10795	434-440	Protein	denotes	IL-1RA
T10794	303-309	Protein	denotes	NFIL-6
T10793	286-290	Protein	denotes	NFAT
T10792	214-220	Protein	denotes	IL-1RA
T10791	164-170	Protein	denotes	IL-1RA
T10790	51-57	Protein	denotes	IL-1RA
T25824	2009-2016	Negative_regulation	denotes	reduced
T25823	1959-1969	Negative_regulation	denotes	Inhibition
T25822	1824-1833	Negative_regulation	denotes	decreased
T25825	2021-2031	Gene_expression	denotes	production
T25821	1812-1820	Positive_regulation	denotes	resulted
T25820	1327-1334	Binding	denotes	binding
T25819	1276-1286	Negative_regulation	denotes	Inhibition
T25818	1290-1300	Positive_regulation	denotes	GP-induced
T25817	1988-1994	Protein	denotes	NFIL-6
T25816	1979-1983	Protein	denotes	NFAT
T25815	2035-2041	Protein	denotes	IL-1RA
T25814	1889-1894	Protein	denotes	GAPDH
T25813	1834-1840	Protein	denotes	IL-1RA
T25812	1805-1811	Protein	denotes	NFIL-6
T25811	1796-1800	Protein	denotes	NFAT
T25810	1342-1348	Protein	denotes	IL-1RA
T25809	1316-1322	Protein	denotes	NFIL-6
T25808	1307-1311	Protein	denotes	NFAT
R17523	T25808	T25820	themeOf	NFAT,binding
R17524	T25808	T25819	themeOf	NFAT,Inhibition
R17525	T25809	T25820	themeOf	NFIL-6,binding
R17526	T25809	T25819	themeOf	NFIL-6,Inhibition
R17527	T25809	T25818	themeOf	NFIL-6,GP-induced
R17528	T25810	T25820	themeOf	IL-1RA,binding
R17529	T25810	T25820	themeOf	IL-1RA,binding
R17530	T25811	T25821	themeOf	NFAT,resulted
R17531	T25811	T25822	causeOf	NFAT,decreased
R17532	T25812	T25821	themeOf	NFIL-6,resulted
R17533	T25812	T25822	causeOf	NFIL-6,decreased
R17534	T25813	T25822	themeOf	IL-1RA,decreased
R17535	T25813	T25822	themeOf	IL-1RA,decreased
R17536	T25815	T25825	themeOf	IL-1RA,production
R17537	T25816	T25824	causeOf	NFAT,reduced
R17538	T25816	T25823	themeOf	NFAT,Inhibition
R17539	T25817	T25823	themeOf	NFIL-6,Inhibition
R17540	T25817	T25824	causeOf	NFIL-6,reduced
R17541	T25823	T25824	causeOf	Inhibition,reduced
R17542	T25823	T25824	causeOf	Inhibition,reduced
R17543	T25825	T25824	themeOf	production,reduced
R17544	T25825	T25824	themeOf	production,reduced
R17545	T25825	T25824	themeOf	production,reduced
R17546	T25825	T25824	themeOf	production,reduced
R7107	T10790	T10802	themeOf	IL-1RA,led
R7108	T10790	T10803	themeOf	IL-1RA,reduced
R7109	T10792	T10804	themeOf	IL-1RA,induction
R7110	T10796	T10805	themeOf	IL-1RA,reduction
R7111	T10797	T10805	themeOf	IL-1RA,reduction
R7112	T10799	T10806	themeOf	IL-1RA,decrease
R7113	T10801	T10807	themeOf	IL-1RA,release
R7114	T10807	T10808	themeOf	release,decreased

DLUT931

Id	Subject	Object	Predicate	Lexical cue
T10876	1240-1249	Negative_regulation	denotes	decreased
T10875	1231-1234	Positive_regulation	denotes	led
T10874	1257-1264	Localization	denotes	release
T10873	454-463	Negative_regulation	denotes	reduction
T10872	244-254	Negative_regulation	denotes	inhibition
T10871	184-192	Positive_regulation	denotes	relevant
T10870	201-210	Positive_regulation	denotes	induction
T10869	36-39	Positive_regulation	denotes	led
T10868	43-50	Negative_regulation	denotes	reduced
T10867	1250-1256	Protein	denotes	IL-1RA
T10866	1032-1038	Protein	denotes	IL-1RA
T10865	920-926	Protein	denotes	IL-1RA
T10864	779-785	Protein	denotes	IL-1RA
T10863	483-489	Protein	denotes	IL-1RA
T10862	467-473	Protein	denotes	IL-1RA
T10861	434-440	Protein	denotes	IL-1RA
T10860	303-309	Protein	denotes	NFIL-6
T10859	286-290	Protein	denotes	NFAT
T10858	214-220	Protein	denotes	IL-1RA
T10857	164-170	Protein	denotes	IL-1RA
T10856	51-57	Protein	denotes	IL-1RA
T25845	2009-2016	Negative_regulation	denotes	reduced
T25844	2056-2065	Positive_regulation	denotes	following
T25843	2021-2031	Gene_expression	denotes	production
T25842	1959-1969	Negative_regulation	denotes	Inhibition
T25841	1824-1833	Negative_regulation	denotes	decreased
T25840	1812-1820	Positive_regulation	denotes	resulted
T25839	1776-1786	Negative_regulation	denotes	Inhibition
T25838	1327-1334	Binding	denotes	binding
T25837	1290-1300	Positive_regulation	denotes	GP-induced
T25836	1276-1286	Negative_regulation	denotes	Inhibition
T25835	1988-1994	Protein	denotes	NFIL-6
T25834	1979-1983	Protein	denotes	NFAT
T25833	2035-2041	Protein	denotes	IL-1RA
T25832	1889-1894	Protein	denotes	GAPDH
T25831	1834-1840	Protein	denotes	IL-1RA
T25830	1805-1811	Protein	denotes	NFIL-6
T25829	1796-1800	Protein	denotes	NFAT
T25828	1342-1348	Protein	denotes	IL-1RA
T25827	1316-1322	Protein	denotes	NFIL-6
T25826	1307-1311	Protein	denotes	NFAT
R7131	T10856	T10868	themeOf	IL-1RA,reduced
R7132	T10858	T10870	themeOf	IL-1RA,induction
R7133	T10859	T10872	themeOf	NFAT,inhibition
R7134	T10862	T10873	themeOf	IL-1RA,reduction
R7135	T10863	T10873	themeOf	IL-1RA,reduction
R7136	T10867	T10874	themeOf	IL-1RA,release
R7137	T10868	T10869	themeOf	reduced,led
R7138	T10870	T10871	themeOf	induction,relevant
R7139	T10874	T10875	themeOf	release,led
R7140	T10874	T10876	themeOf	release,decreased
R17547	T25826	T25836	themeOf	NFAT,Inhibition
R17548	T25826	T25837	themeOf	NFAT,GP-induced
R17549	T25826	T25838	themeOf	NFAT,binding
R17550	T25828	T25838	themeOf	IL-1RA,binding
R17551	T25829	T25840	themeOf	NFAT,resulted
R17552	T25830	T25839	themeOf	NFIL-6,Inhibition
R17553	T25830	T25840	themeOf	NFIL-6,resulted
R17554	T25831	T25841	themeOf	IL-1RA,decreased
R17555	T25833	T25843	themeOf	IL-1RA,production
R17556	T25834	T25842	themeOf	NFAT,Inhibition
R17557	T25835	T25842	themeOf	NFIL-6,Inhibition
R17558	T25836	T25837	themeOf	Inhibition,GP-induced
R17559	T25837	T25836	themeOf	GP-induced,Inhibition
R17560	T25837	T25836	themeOf	GP-induced,Inhibition
R17561	T25839	T25840	themeOf	Inhibition,resulted
R17562	T25841	T25840	themeOf	decreased,resulted
R17563	T25842	T25845	causeOf	Inhibition,reduced
R17564	T25842	T25845	causeOf	Inhibition,reduced
R17565	T25843	T25844	themeOf	production,following
R17566	T25843	T25845	themeOf	production,reduced
R17567	T25843	T25845	themeOf	production,reduced

bionlp-st-ge-2016-test-ihmc

Id	Subject	Object	Predicate	Lexical cue
T26135	1956-2041	Negative_regulation	denotes	C, Inhibition of NFκB, NFAT and NFIL-6 significantly reduced the production of IL-1RA
T26134	1643-1664	Negative_regulation	denotes	a decrease in binding
T26133	2017-2041	Gene_expression	denotes	the production of IL-1RA
T26132	1776-1794	Negative_regulation	denotes	Inhibition of NFκB
T26131	1301-1357	Binding	denotes	NFκB, NFAT and NFIL-6 DNA binding to the IL-1RA promoter
T26130	1906-1926	Regulation	denotes	housekeeping control
T26129	1796-1800	Protein	denotes	NFAT
T26128	1307-1311	Protein	denotes	NFAT
T26127	1765-1768	Entity	denotes	n =
T26126	1342-1348	Protein	denotes	IL-1RA
T26125	2051-2075	Entity	denotes	PBMC following treatment
T26124	1335-1357	Entity	denotes	to the IL-1RA promoter
T26123	1824-1845	Protein	denotes	decreased IL-1RA mRNA
T26122	1419-1421	Protein	denotes	GP
T26121	2138-2139	Entity	denotes	p
T26120	1301-1305	Protein	denotes	NFκB
T26119	1787-1794	Protein	denotes	of NFκB
T26118	1515-1517	Protein	denotes	GP
T26117	2123-2124	Entity	denotes	p
T26116	1988-1994	Protein	denotes	NFIL-6
T26115	1497-1499	Protein	denotes	GP
T26114	1301-1326	Entity	denotes	NFκB, NFAT and NFIL-6 DNA
T26113	1943-1954	Entity	denotes	gel, n = 4)
T26112	1722-1727	Entity	denotes	= p <
T26111	2032-2041	Protein	denotes	of IL-1RA
T26110	1834-1840	Protein	denotes	IL-1RA
T26109	1973-1977	Protein	denotes	NFκB
T26108	2179-2182	Entity	denotes	n =
T26107	1805-1811	Protein	denotes	NFIL-6
T26106	1316-1322	Protein	denotes	NFIL-6
T26105	1533-1535	Protein	denotes	GP
T26104	1889-1894	Protein	denotes	GAPDH
T26103	1483-1499	Protein	denotes	CAPE, lane 5: GP
T26102	1614-1632	Entity	denotes	the NFATP2/3 site,
T26101	1979-1983	Protein	denotes	NFAT
T11234	241-285	Negative_regulation	denotes	an inhibition of NFκB via CAPE [35] and CyA,
T11233	0-64	Negative_regulation	denotes	Inhibition of transcription factors led to reduced IL-1RA levels
T11232	694-727	Binding	denotes	the NFκB and NFIL-6 binding sites
T11231	694-727	Entity	denotes	the NFκB and NFIL-6 binding sites
T11230	1113-1117	Protein	denotes	NFκB
T11229	920-926	Protein	denotes	IL-1RA
T11228	160-179	Entity	denotes	the IL-1RA promoter
T11227	434-440	Protein	denotes	IL-1RA
T11226	842-843	Entity	denotes	h
T11225	483-504	Protein	denotes	IL-1RA protein levels
T11224	988-991	Protein	denotes	Fig
T11223	430-447	Entity	denotes	the IL-1RA sites,
T11222	871-971	Entity	denotes	A representative gel demonstrating a decrease in IL-1RA mRNA after inhibition with CAPE, CyA and CHX
T11221	1063-1070	Entity	denotes	h of GP
T11220	81-91	Entity	denotes	inhibitors
T11219	467-473	Protein	denotes	IL-1RA
T11218	506-509	Protein	denotes	Fig
T11217	164-170	Protein	denotes	IL-1RA
T11216	255-262	Protein	denotes	of NFκB
T11215	707-713	Protein	denotes	NFIL-6
T11214	698-702	Protein	denotes	NFκB
T11213	812-816	Protein	denotes	mRNA
T11212	862-869	Entity	denotes	h of GP
T11211	997-998	Entity	denotes	n
T11210	1032-1062	Protein	denotes	IL-1RA protein levels after 24
T11209	917-931	Protein	denotes	in IL-1RA mRNA
T11208	211-220	Protein	denotes	of IL-1RA
T11207	649-652	Entity	denotes	n =
T11206	51-57	Protein	denotes	IL-1RA
T11205	286-290	Protein	denotes	NFAT
T11204	303-309	Protein	denotes	NFIL-6
T11203	1250-1256	Protein	denotes	IL-1RA
T11202	1032-1038	Protein	denotes	IL-1RA
T11201	122-152	Entity	denotes	the transcription factor sites
T11200	467-478	Protein	denotes	IL-1RA mRNA
T11199	1093-1096	Entity	denotes	n =
T11198	483-489	Protein	denotes	IL-1RA
T11197	767-792	Protein	denotes	the highest IL-1RA amount
R7419	T11216	T11234	themeOf	of NFκB,"an inhibition of NFκB via CAPE [35] and CyA,"
R7420	T11228	T11217	partOf	the IL-1RA promoter,IL-1RA
R7421	T11231	T11232	themeOf	the NFκB and NFIL-6 binding sites,the NFκB and NFIL-6 binding sites
R17803	T26111	T26133	themeOf	of IL-1RA,the production of IL-1RA
R17804	T26114	T26131	themeOf	"NFκB, NFAT and NFIL-6 DNA","NFκB, NFAT and NFIL-6 DNA binding to the IL-1RA promoter"
R17805	T26119	T26132	themeOf	of NFκB,Inhibition of NFκB
R17806	T26124	T26126	partOf	to the IL-1RA promoter,IL-1RA
R17807	T26124	T26131	themeOf	to the IL-1RA promoter,"NFκB, NFAT and NFIL-6 DNA binding to the IL-1RA promoter"
R17808	T26133	T26135	themeOf	the production of IL-1RA,"C, Inhibition of NFκB, NFAT and NFIL-6 significantly reduced the production of IL-1RA"

bionlp-st-ge-2016-spacy-parsed

Id	Subject	Object	Predicate	Lexical cue
T26048	2118-2119	-LRB-	denotes	(
T26047	2115-2117	NNP	denotes	GP
T26046	2112-2114	TO	denotes	to
T26045	2103-2111	VBN	denotes	compared
T26044	2098-2102	WRB	denotes	when
T26043	2094-2097	NNP	denotes	CyA
T26042	2091-2093	CC	denotes	or
T26041	2086-2090	NNP	denotes	CAPE
T26040	2084-2085	,	denotes	,
T26039	2081-2084	NNP	denotes	CHX
T26038	2076-2080	IN	denotes	with
T26037	2066-2075	NN	denotes	treatment
T26036	2056-2065	VBG	denotes	following
T26035	2051-2055	NNP	denotes	PBMC
T26034	2045-2050	JJ	denotes	human
T26033	2042-2044	IN	denotes	by
T26032	2035-2041	NN	denotes	IL-1RA
T26031	2032-2034	IN	denotes	of
T26030	2021-2031	NN	denotes	production
T26029	2017-2020	DT	denotes	the
T26028	2009-2016	VBD	denotes	reduced
T26027	1995-2008	RB	denotes	significantly
T26026	1988-1994	NNP	denotes	NFIL-6
T26025	1984-1987	CC	denotes	and
T26024	1979-1983	NNP	denotes	NFAT
T26023	1977-1978	,	denotes	,
T26022	1973-1977	NNP	denotes	NFκB
T26021	1970-1972	IN	denotes	of
T26020	1959-1969	NNP	denotes	Inhibition
T26019	1957-1958	,	denotes	,
T26018	1956-1957	NNP	denotes	C
T26017	1954-1955	.	denotes	.
T26016	1953-1954	-RRB-	denotes	)
T26015	1952-1953	LS	denotes	4
T26014	1950-1951	SYM	denotes	=
T26013	1948-1949	NN	denotes	n
T26012	1946-1947	,	denotes	,
T26011	1943-1946	NN	denotes	gel
T26010	1928-1942	JJ	denotes	representative
T26009	1927-1928	-LRB-	denotes	(
T26008	1919-1926	NN	denotes	control
T26007	1906-1918	NN	denotes	housekeeping
T26006	1903-1905	IN	denotes	as
T26005	1898-1902	VBN	denotes	used
T26004	1895-1897	VBZ	denotes	is
T26003	1889-1894	NNP	denotes	GAPDH
T26002	1887-1888	.	denotes	.
T26001	1885-1887	NNP	denotes	GP
T26000	1882-1884	TO	denotes	to
T25999	1873-1881	VBN	denotes	compared
T25998	1869-1872	NNP	denotes	CyA
T25997	1866-1868	CC	denotes	or
T25996	1861-1865	NNP	denotes	CAPE
T25995	1859-1860	,	denotes	,
T25994	1856-1859	NNP	denotes	CHX
T25993	1846-1855	VBG	denotes	following
T25992	1841-1845	NNP	denotes	mRNA
T25991	1834-1840	NNP	denotes	IL-1RA
T25990	1824-1833	VBN	denotes	decreased
T25989	1821-1823	IN	denotes	in
T25988	1812-1820	VBD	denotes	resulted
T25987	1805-1811	NNP	denotes	NFIL-6
T25986	1801-1804	CC	denotes	and
T25985	1796-1800	NNP	denotes	NFAT
T25984	1794-1795	,	denotes	,
T25983	1790-1794	NNP	denotes	NFκB
T25982	1787-1789	IN	denotes	of
T25981	1776-1786	NNP	denotes	Inhibition
T25980	1774-1775	,	denotes	,
T25979	1773-1774	NNP	denotes	B
T25978	1771-1772	.	denotes	.
T25977	1770-1771	-RRB-	denotes	)
T25976	1769-1770	LS	denotes	4
T25975	1767-1768	SYM	denotes	=
T25974	1765-1766	FW	denotes	n
T25973	1764-1765	-LRB-	denotes	(
T25972	1760-1763	NNP	denotes	SEM
T25971	1758-1759	NN	denotes	±
T25970	1753-1757	JJ	denotes	mean
T25969	1750-1752	IN	denotes	as
T25968	1744-1749	VBN	denotes	shown
T25967	1740-1743	VBP	denotes	are
T25966	1735-1739	NNS	denotes	Data
T25965	1733-1734	.	denotes	.
T25964	1732-1733	-RRB-	denotes	)
T25963	1728-1732	CD	denotes	0.05
T25962	1726-1727	FW	denotes	<
T25961	1724-1725	FW	denotes	p
T25960	1722-1723	SYM	denotes	=
T25959	1720-1721	SYM	denotes	*
T25958	1719-1720	-LRB-	denotes	(
T25957	1709-1718	VBN	denotes	displayed
T25956	1706-1708	VBZ	denotes	is
T25955	1703-1705	NNP	denotes	GP
T25954	1700-1702	TO	denotes	to
T25953	1691-1699	VBN	denotes	compared
T25952	1686-1690	WRB	denotes	when
T25951	1675-1685	NN	denotes	inhibition
T25950	1665-1674	JJ	denotes	following
T25949	1657-1664	JJ	denotes	binding
T25948	1654-1656	IN	denotes	in
T25947	1645-1653	NN	denotes	decrease
T25946	1643-1644	DT	denotes	a
T25945	1633-1642	VBG	denotes	depicting
T25944	1631-1632	,	denotes	,
T25943	1627-1631	NN	denotes	site
T25942	1618-1626	NNP	denotes	NFATP2/3
T25941	1614-1617	DT	denotes	the
T25940	1610-1613	IN	denotes	for
T25939	1602-1609	NN	denotes	summary
T25938	1592-1601	JJ	denotes	graphical
T25937	1590-1591	DT	denotes	a
T25936	1587-1589	IN	denotes	as
T25935	1582-1586	RB	denotes	well
T25934	1579-1581	RB	denotes	as
T25933	1577-1578	-RRB-	denotes	)
T25932	1572-1577	NN	denotes	water
T25931	1570-1571	:	denotes	:
T25930	1569-1570	CD	denotes	8
T25929	1564-1568	NN	denotes	lane
T25928	1562-1563	,	denotes	,
T25927	1557-1562	NN	denotes	oligo
T25926	1548-1556	NNP	denotes	NFATP2/3
T25925	1538-1547	JJ	denotes	unlabeled
T25924	1536-1537	NNP	denotes	+
T25923	1533-1535	NNP	denotes	GP
T25922	1531-1532	:	denotes	:
T25921	1530-1531	CD	denotes	7
T25920	1525-1529	NN	denotes	lane
T25919	1523-1524	,	denotes	,
T25918	1520-1523	NNP	denotes	CHX
T25917	1518-1519	NNP	denotes	+
T25916	1515-1517	NNP	denotes	GP
T25915	1513-1514	:	denotes	:
T25914	1512-1513	CD	denotes	6
T25913	1507-1511	NN	denotes	lane
T25912	1505-1506	,	denotes	,
T25911	1502-1505	NNP	denotes	CyA
T25910	1500-1501	NNP	denotes	+
T25909	1497-1499	NNP	denotes	GP
T25908	1495-1496	:	denotes	:
T25907	1494-1495	CD	denotes	5
T25906	1489-1493	NN	denotes	lane
T25905	1487-1488	,	denotes	,
T25904	1483-1487	NNP	denotes	CAPE
T25903	1481-1482	NNP	denotes	+
T25902	1478-1480	NNP	denotes	GP
T25901	1476-1477	:	denotes	:
T25900	1475-1476	CD	denotes	4
T25899	1470-1474	NN	denotes	lane
T25898	1468-1469	,	denotes	,
T25897	1463-1468	NN	denotes	oligo
T25896	1454-1462	CD	denotes	NFATP2/3
T25895	1446-1453	VBD	denotes	mutated
T25894	1436-1445	JJ	denotes	unlabeled
T25893	1434-1435	NNP	denotes	+
T25892	1431-1433	NNP	denotes	GP
T25891	1429-1430	:	denotes	:
T25890	1428-1429	CD	denotes	3
T25889	1423-1427	NN	denotes	lane
T25888	1421-1422	,	denotes	,
T25887	1419-1421	NNP	denotes	GP
T25886	1417-1418	:	denotes	:
T25885	1416-1417	CD	denotes	2
T25884	1411-1415	NN	denotes	lane
T25883	1409-1410	,	denotes	,
T25882	1402-1409	NN	denotes	control
T25881	1400-1401	:	denotes	:
T25880	1399-1400	CD	denotes	1
T25879	1394-1398	NN	denotes	lane
T25878	1393-1394	-LRB-	denotes	(
T25877	1379-1392	NN	denotes	autoradiogram
T25876	1364-1378	JJ	denotes	representative
T25875	1362-1363	DT	denotes	A
T25874	1360-1361	,	denotes	,
T25873	1359-1360	DT	denotes	A
T25872	1357-1358	.	denotes	.
T25871	1349-1357	NN	denotes	promoter
T25870	1342-1348	NN	denotes	IL-1RA
T25869	1338-1341	DT	denotes	the
T25868	1335-1337	TO	denotes	to
T25867	1327-1334	JJ	denotes	binding
T25866	1323-1326	NNP	denotes	DNA
T25865	1316-1322	NNP	denotes	NFIL-6
T25864	1312-1315	CC	denotes	and
T25863	1307-1311	NNP	denotes	NFAT
T25862	1305-1306	,	denotes	,
T25861	1301-1305	NNP	denotes	NFκB
T25860	1290-1300	NNP	denotes	GP-induced
T25859	1287-1289	IN	denotes	of
T25858	1276-1286	NNP	denotes	Inhibition
T26074	2185-2186	.	denotes	.
T26073	2184-2185	-RRB-	denotes	)
T26072	2183-2184	LS	denotes	3
T26071	2181-2182	SYM	denotes	=
T26070	2179-2180	FW	denotes	n
T26069	2178-2179	-LRB-	denotes	(
T26068	2174-2177	NNP	denotes	SEM
T26067	2172-2173	NN	denotes	±
T26066	2167-2171	JJ	denotes	mean
T26065	2164-2166	IN	denotes	as
T26064	2158-2163	VBN	denotes	shown
T26063	2154-2157	VBP	denotes	are
T26062	2149-2153	NNS	denotes	Data
T26061	2147-2148	.	denotes	.
T26060	2146-2147	-RRB-	denotes	)
T26059	2142-2146	CD	denotes	0.01
T26058	2140-2141	FW	denotes	<
T26057	2138-2139	FW	denotes	p
T26056	2136-2137	SYM	denotes	=
T26055	2133-2135	SYM	denotes	**
T26054	2131-2132	:	denotes	;
T26053	2127-2131	CD	denotes	0.05
T26052	2125-2126	FW	denotes	<
T26051	2123-2124	FW	denotes	p
T26050	2121-2122	SYM	denotes	=
T26049	2119-2120	SYM	denotes	*
T11121	1141-1145	RBR	denotes	more
T11120	1137-1140	VBD	denotes	was
T11119	1132-1136	NNP	denotes	CAPE
T11118	1129-1131	IN	denotes	by
T11117	1118-1128	NN	denotes	inhibition
T11116	1113-1117	NNP	denotes	NFκB
T11115	1111-1112	,	denotes	,
T11114	1101-1111	RB	denotes	Altogether
T11113	1099-1100	.	denotes	.
T11112	1098-1099	-RRB-	denotes	)
T11111	1097-1098	LS	denotes	3
T11110	1095-1096	SYM	denotes	=
T11109	1093-1094	FW	denotes	n
T11108	1092-1093	-LRB-	denotes	(
T11107	1089-1091	NNP	denotes	7C
T11106	1084-1088	NNP	denotes	Fig.
T11105	1081-1083	IN	denotes	in
T11104	1075-1080	VBN	denotes	shown
T11103	1071-1074	VBP	denotes	are
T11102	1068-1070	NNP	denotes	GP
T11101	1065-1067	IN	denotes	of
T11100	1063-1064	NN	denotes	h
T11099	1060-1062	CD	denotes	24
T11098	1054-1059	IN	denotes	after
T11097	1047-1053	NNS	denotes	levels
T11096	1039-1046	NN	denotes	protein
T11095	1032-1038	NN	denotes	IL-1RA
T11094	1018-1031	JJ	denotes	corresponding
T11093	1016-1017	,	denotes	,
T11092	1008-1016	NN	denotes	addition
T11091	1005-1007	IN	denotes	In
T11037	756-757	-RRB-	denotes	)
T11036	751-756	VBN	denotes	shown
T11035	747-750	RB	denotes	not
T11034	742-746	NNS	denotes	data
T11033	741-742	-LRB-	denotes	(
T11032	733-740	JJ	denotes	similar
T11031	728-732	VBD	denotes	were
T11030	722-727	NNS	denotes	sites
T11029	714-721	JJ	denotes	binding
T11028	707-713	NNP	denotes	NFIL-6
T11027	703-706	CC	denotes	and
T11026	698-702	NNP	denotes	NFκB
T11025	694-697	DT	denotes	the
T11024	690-693	IN	denotes	for
T11023	682-689	NNS	denotes	results
T11022	678-681	DT	denotes	The
T11021	676-677	.	denotes	.
T11020	675-676	-RRB-	denotes	)
T11019	671-675	NN	denotes	side
T11018	665-670	JJ	denotes	right
T11017	663-664	,	denotes	,
T11016	661-663	NN	denotes	7A
T11015	656-660	NNP	denotes	Fig.
T11014	654-655	,	denotes	,
T11013	653-654	CD	denotes	4
T11012	651-652	SYM	denotes	=
T11011	649-650	FW	denotes	n
T11010	648-649	-LRB-	denotes	(
T11009	637-647	VBN	denotes	summarized
T11008	625-636	RB	denotes	graphically
T11007	621-624	CC	denotes	and
T11006	619-620	-RRB-	denotes	)
T11005	615-619	NN	denotes	side
T11004	610-614	VBD	denotes	left
T11003	608-609	,	denotes	,
T11002	606-608	NN	denotes	7A
T11001	601-605	NNP	denotes	Fig.
T11000	600-601	-LRB-	denotes	(
T10999	586-599	NN	denotes	autoradiogram
T10998	583-585	DT	denotes	an
T10997	580-582	IN	denotes	in
T10939	284-285	,	denotes	,
T10938	281-284	NNP	denotes	CyA
T10937	277-280	CC	denotes	and
T10936	275-276	NNP	denotes	]
T10935	273-275	CD	denotes	35
T10934	272-273	NNP	denotes	[
T10933	267-271	NNP	denotes	CAPE
T10932	263-266	IN	denotes	via
T10931	258-262	NNP	denotes	NFκB
T10930	255-257	IN	denotes	of
T10929	244-254	NN	denotes	inhibition
T10928	241-243	DT	denotes	an
T10927	239-240	,	denotes	,
T10926	231-239	VBN	denotes	expected
T10925	228-230	IN	denotes	As
T10924	226-227	.	denotes	.
T10923	224-226	NNP	denotes	GP
T10922	221-223	IN	denotes	by
T10921	214-220	NN	denotes	IL-1RA
T10920	211-213	IN	denotes	of
T10919	201-210	NN	denotes	induction
T10918	197-200	DT	denotes	the
T10917	193-196	IN	denotes	for
T10916	184-192	JJ	denotes	relevant
T10915	180-183	VBP	denotes	are
T10914	171-179	NN	denotes	promoter
T10913	164-170	NN	denotes	IL-1RA
T10912	160-163	DT	denotes	the
T10911	153-159	IN	denotes	within
T10910	147-152	NNS	denotes	sites
T10909	140-146	NN	denotes	factor
T10908	126-139	NN	denotes	transcription
T10907	122-125	DT	denotes	the
T10906	117-121	IN	denotes	that
T11142	1264-1265	.	denotes	.
T11141	1257-1264	NN	denotes	release
T11140	1250-1256	NN	denotes	IL-1RA
T11139	1240-1249	VBN	denotes	decreased
T11138	1238-1239	DT	denotes	a
T11137	1235-1237	TO	denotes	to
T11136	1231-1234	VBD	denotes	led
T11135	1224-1230	RB	denotes	mainly
T11134	1220-1223	NNP	denotes	CHX
T11133	1216-1219	CC	denotes	and
T11132	1212-1215	NNP	denotes	CyA
T11131	1204-1211	IN	denotes	whereas
T11130	1202-1203	,	denotes	,
T11129	1189-1202	NN	denotes	transcription
T11128	1185-1188	DT	denotes	the
T11127	1181-1184	CC	denotes	and
T11126	1172-1180	NN	denotes	activity
T11125	1164-1171	JJ	denotes	binding
T11124	1160-1163	DT	denotes	the
T11123	1157-1159	IN	denotes	at
T11122	1146-1156	JJ	denotes	pronounced
T10905	105-116	VB	denotes	demonstrate
T10904	102-104	TO	denotes	to
T10903	97-101	VBN	denotes	used
T10902	92-96	VBD	denotes	were
T10901	81-91	NNS	denotes	inhibitors
T10900	65-80	JJ	denotes	Pharmacological
T10899	58-64	NNS	denotes	levels
T10898	51-57	NN	denotes	IL-1RA
T10897	43-50	VBN	denotes	reduced
T10896	40-42	TO	denotes	to
T10895	36-39	VBD	denotes	led
T10894	28-35	NNS	denotes	factors
T10893	14-27	NN	denotes	transcription
T10892	11-13	IN	denotes	of
T10891	0-10	NNP	denotes	Inhibition
T10967	427-429	TO	denotes	to
T10966	419-426	NNS	denotes	factors
T10965	405-418	NN	denotes	transcription
T10964	401-404	DT	denotes	the
T10963	398-400	IN	denotes	of
T10962	389-397	NN	denotes	activity
T10961	381-388	JJ	denotes	binding
T10960	366-380	JJ	denotes	down-regulated
T10959	364-365	DT	denotes	a
T10958	361-363	TO	denotes	to
T10957	353-360	VBG	denotes	leading
T10956	351-352	,	denotes	,
T10955	349-351	NNP	denotes	GP
T10954	346-348	IN	denotes	by
T10953	336-345	VBN	denotes	overruled
T10952	333-335	VB	denotes	be
T10951	329-332	RB	denotes	not
T10950	323-328	MD	denotes	could
T10949	321-322	NNP	denotes	]
T10948	319-321	CD	denotes	36
T10947	318-319	NNP	denotes	[
T10946	314-317	NNP	denotes	CHX
T10945	310-313	IN	denotes	via
T10944	303-309	NNP	denotes	NFIL-6
T10943	299-302	CC	denotes	and
T10942	295-298	NNP	denotes	CyA
T10941	291-294	IN	denotes	via
T10940	286-290	NNP	denotes	NFAT
T10996	574-579	VBN	denotes	shown
T10995	562-573	RB	denotes	exemplarily
T10994	559-561	VBZ	denotes	is
T10993	551-558	JJ	denotes	binding
T10992	542-550	CD	denotes	NFATP2/3
T10991	539-541	IN	denotes	in
T10990	529-538	NN	denotes	reduction
T10989	526-528	IN	denotes	of
T10988	519-525	NN	denotes	extent
T10987	515-518	DT	denotes	The
T10986	513-514	.	denotes	.
T10985	512-513	-RRB-	denotes	)
T10984	511-512	CD	denotes	7
T10983	506-510	NN	denotes	Fig.
T10982	505-506	-LRB-	denotes	(
T10981	498-504	NNS	denotes	levels
T10980	490-497	NN	denotes	protein
T10979	483-489	NNP	denotes	IL-1RA
T10978	479-482	CC	denotes	and
T10977	474-478	NNP	denotes	mRNA
T10976	467-473	NNP	denotes	IL-1RA
T10975	464-466	IN	denotes	of
T10974	454-463	NN	denotes	reduction
T10973	452-453	DT	denotes	a
T10972	448-451	CC	denotes	and
T10971	446-447	,	denotes	,
T10970	441-446	NNS	denotes	sites
T10969	434-440	NN	denotes	IL-1RA
T10968	430-433	DT	denotes	the
T11063	871-872	DT	denotes	A
T11062	869-870	.	denotes	.
T11061	867-869	NNP	denotes	GP
T11060	864-866	IN	denotes	of
T11059	862-863	NN	denotes	h
T11058	859-861	CD	denotes	18
T11057	855-858	CC	denotes	and
T11056	844-854	NN	denotes	inhibition
T11055	842-843	NN	denotes	h
T11054	840-841	CD	denotes	1
T11053	830-839	VBG	denotes	following
T11052	821-829	VBN	denotes	examined
T11051	817-820	VBD	denotes	was
T11050	812-816	NNP	denotes	mRNA
T11049	810-811	,	denotes	,
T11048	809-810	NN	denotes	h
T11047	806-808	CD	denotes	24
T11046	803-805	IN	denotes	at
T11045	797-802	VBN	denotes	found
T11044	793-796	VBD	denotes	was
T11043	786-792	NN	denotes	amount
T11042	779-785	NN	denotes	IL-1RA
T11041	771-778	JJS	denotes	highest
T11040	767-770	DT	denotes	the
T11039	759-766	IN	denotes	Because
T11038	757-758	.	denotes	.
T11076	958-959	,	denotes	,
T11090	1003-1004	.	denotes	.
T11089	1002-1003	-RRB-	denotes	)
T11088	1001-1002	LS	denotes	4
T11087	999-1000	SYM	denotes	=
T11086	997-998	FW	denotes	n
T11085	996-997	-LRB-	denotes	(
T11084	993-995	NN	denotes	7B
T11083	988-992	NNP	denotes	Fig.
T11082	985-987	IN	denotes	in
T11081	975-984	VBN	denotes	displayed
T11080	972-974	VBZ	denotes	is
T11079	968-971	NNP	denotes	CHX
T11078	964-967	CC	denotes	and
T11077	960-963	NNP	denotes	CyA
T11075	954-958	NNP	denotes	CAPE
T11074	949-953	IN	denotes	with
T11073	938-948	NN	denotes	inhibition
T11072	932-937	IN	denotes	after
T11071	927-931	NNP	denotes	mRNA
T11070	920-926	NNP	denotes	IL-1RA
T11069	917-919	IN	denotes	in
T11068	908-916	NN	denotes	decrease
T11067	906-907	DT	denotes	a
T11066	892-905	VBG	denotes	demonstrating
T11065	888-891	NN	denotes	gel
T11064	873-887	JJ	denotes	representative
R7278	T11026	T11030	nmod	NFκB,sites
R7279	T11027	T11026	cc	and,NFκB
R7280	T11028	T11026	conj	NFIL-6,NFκB
R7281	T11029	T11030	amod	binding,sites
R7282	T11030	T11024	pobj	sites,for
R7283	T11031	T11031	ROOT	were,were
R7284	T11032	T11031	acomp	similar,were
R7285	T11033	T11036	punct	(,shown
R7286	T11034	T11036	nsubjpass	data,shown
R7287	T11035	T11036	neg	not,shown
R7288	T11036	T11031	parataxis	shown,were
R7289	T11037	T11036	punct	),shown
R7290	T11038	T11031	punct	.,were
R7291	T11039	T11045	mark	Because,found
R7292	T11040	T11043	det	the,amount
R7293	T11041	T11043	amod	highest,amount
R7294	T11042	T11043	compound	IL-1RA,amount
R7295	T11043	T11045	nsubjpass	amount,found
R7296	T11044	T11045	auxpass	was,found
R7297	T11045	T11052	advcl	found,examined
R7298	T11046	T11045	prep	at,found
R7299	T11047	T11048	nummod	24,h
R7300	T11048	T11046	pobj	h,at
R7301	T11049	T11052	punct	",",examined
R7302	T11050	T11052	nsubjpass	mRNA,examined
R7303	T11051	T11052	auxpass	was,examined
R7304	T11052	T11052	ROOT	examined,examined
R7305	T11053	T11052	prep	following,examined
R7306	T11054	T11056	nummod	1,inhibition
R7307	T11055	T11056	compound	h,inhibition
R7308	T11056	T11053	pobj	inhibition,following
R7309	T11057	T11056	cc	and,inhibition
R7310	T11058	T11059	nummod	18,h
R7311	T11059	T11056	conj	h,inhibition
R7312	T11060	T11059	prep	of,h
R7313	T11061	T11060	pobj	GP,of
R7314	T11062	T11052	punct	.,examined
R7315	T11063	T11065	det	A,gel
R7316	T11064	T11065	compound	representative,gel
R7317	T11065	T11081	nsubjpass	gel,displayed
R7318	T11066	T11065	acl	demonstrating,gel
R7319	T11067	T11068	det	a,decrease
R7320	T11068	T11066	dobj	decrease,demonstrating
R7321	T11069	T11068	prep	in,decrease
R7322	T11070	T11071	compound	IL-1RA,mRNA
R7323	T11071	T11069	pobj	mRNA,in
R7324	T11072	T11066	prep	after,demonstrating
R7325	T11073	T11072	pobj	inhibition,after
R7326	T11074	T11073	prep	with,inhibition
R7327	T11075	T11074	pobj	CAPE,with
R7328	T11076	T11075	punct	",",CAPE
R7329	T11077	T11075	conj	CyA,CAPE
R7330	T11078	T11077	cc	and,CyA
R7331	T11079	T11077	conj	CHX,CyA
R7332	T11080	T11081	auxpass	is,displayed
R7333	T11081	T11081	ROOT	displayed,displayed
R7334	T11082	T11081	prep	in,displayed
R7335	T11083	T11084	compound	Fig.,7B
R7336	T11084	T11082	pobj	7B,in
R7337	T11085	T11088	punct	(,4
R7338	T11086	T11087	advmod	n,=
R7339	T11087	T11088	punct	=,4
R7340	T11088	T11081	parataxis	4,displayed
R7341	T11089	T11088	punct	),4
R7342	T11090	T11081	punct	.,displayed
R7343	T11091	T11104	prep	In,shown
R7344	T11092	T11091	pobj	addition,In
R7345	T11093	T11104	punct	",",shown
R7346	T11094	T11097	amod	corresponding,levels
R7347	T11095	T11097	compound	IL-1RA,levels
R7348	T11096	T11097	compound	protein,levels
R7349	T11097	T11104	nsubjpass	levels,shown
R7350	T11098	T11097	prep	after,levels
R7351	T11099	T11100	nummod	24,h
R7352	T11100	T11098	pobj	h,after
R7353	T11101	T11100	prep	of,h
R7354	T11102	T11101	pobj	GP,of
R7355	T11103	T11104	auxpass	are,shown
R7356	T11104	T11104	ROOT	shown,shown
R7357	T11105	T11104	prep	in,shown
R7358	T11106	T11107	compound	Fig.,7C
R7359	T11107	T11105	pobj	7C,in
R7360	T11108	T11111	punct	(,3
R7361	T11109	T11111	advmod	n,3
R7362	T11110	T11111	punct	=,3
R7363	T11111	T11107	appos	3,7C
R7364	T11112	T11111	punct	),3
R7365	T11113	T11104	punct	.,shown
R7366	T11114	T11120	advmod	Altogether,was
R7367	T11115	T11120	punct	",",was
R7368	T11116	T11117	compound	NFκB,inhibition
R7369	T11117	T11120	nsubj	inhibition,was
R7370	T11118	T11117	prep	by,inhibition
R7371	T11119	T11118	pobj	CAPE,by
R7372	T11120	T11120	ROOT	was,was
R7373	T11121	T11122	advmod	more,pronounced
R7374	T11122	T11120	acomp	pronounced,was
R7375	T11123	T11120	prep	at,was
R7376	T11124	T11126	det	the,activity
R7377	T11125	T11126	amod	binding,activity
R7378	T11126	T11123	pobj	activity,at
R7379	T11127	T11120	cc	and,was
R7380	T11128	T11129	det	the,transcription
R7381	T11129	T11120	conj	transcription,was
R7382	T11130	T11120	punct	",",was
R7383	T11131	T11136	mark	whereas,led
R7384	T11132	T11136	nsubj	CyA,led
R7385	T11133	T11132	cc	and,CyA
R7386	T11134	T11132	conj	CHX,CyA
R7387	T11135	T11136	advmod	mainly,led
R7388	T11136	T11120	advcl	led,was
R7389	T11137	T11136	prep	to,led
R7390	T11138	T11141	det	a,release
R7391	T11139	T11141	amod	decreased,release
R7392	T11140	T11141	compound	IL-1RA,release
R7393	T11141	T11137	pobj	release,to
R7394	T11142	T11120	punct	.,was
R17571	T25858	T25858	ROOT	Inhibition,Inhibition
R17572	T25859	T25858	prep	of,Inhibition
R17573	T25860	T25861	compound	GP-induced,NFκB
R17574	T25861	T25859	pobj	NFκB,of
R17575	T25862	T25861	punct	",",NFκB
R17576	T25863	T25861	conj	NFAT,NFκB
R17577	T25864	T25863	cc	and,NFAT
R17578	T25865	T25866	compound	NFIL-6,DNA
R17579	T25866	T25863	conj	DNA,NFAT
R17580	T25867	T25858	conj	binding,Inhibition
R17581	T25868	T25867	prep	to,binding
R17582	T25869	T25871	det	the,promoter
R17583	T25870	T25871	compound	IL-1RA,promoter
R17584	T25871	T25868	pobj	promoter,to
R17585	T25872	T25858	punct	.,Inhibition
R17586	T25873	T25957	nsubjpass	A,displayed
R17587	T25874	T25873	punct	",",A
R17588	T25875	T25877	det	A,autoradiogram
R17589	T25876	T25877	amod	representative,autoradiogram
R17590	T25877	T25889	nsubj	autoradiogram,lane
R17591	T25878	T25877	punct	(,autoradiogram
R17592	T25879	T25877	appos	lane,autoradiogram
R17593	T25880	T25879	nummod	1,lane
R17594	T25881	T25879	punct	:,lane
R17595	T25882	T25879	appos	control,lane
R17596	T25883	T25882	punct	",",control
R17597	T25884	T25877	parataxis	lane,autoradiogram
R17598	T25885	T25884	nummod	2,lane
R17599	T25886	T25884	punct	:,lane
R17600	T25887	T25884	appos	GP,lane
R17601	T25888	T25887	punct	",",GP
R17602	T25889	T25873	appos	lane,A
R17603	T25890	T25889	nummod	3,lane
R17604	T25891	T25889	punct	:,lane
R17605	T25892	T25895	nsubj	GP,mutated
R17606	T25893	T25895	npadvmod	+,mutated
R17607	T25894	T25895	nsubj	unlabeled,mutated
R17608	T25895	T25899	amod	mutated,lane
R17609	T25896	T25897	nummod	NFATP2/3,oligo
R17610	T25897	T25895	dobj	oligo,mutated
R17611	T25898	T25897	punct	",",oligo
R17612	T25899	T25913	compound	lane,lane
R17613	T25900	T25899	nummod	4,lane
R17614	T25901	T25899	punct	:,lane
R17615	T25902	T25904	compound	GP,CAPE
R17616	T25903	T25904	compound	+,CAPE
R17617	T25904	T25899	appos	CAPE,lane
R17618	T25905	T25904	punct	",",CAPE
R17619	T25906	T25899	conj	lane,lane
R17620	T25907	T25906	nummod	5,lane
R17621	T25908	T25899	punct	:,lane
R17622	T25909	T25911	compound	GP,CyA
R17623	T25910	T25911	compound	+,CyA
R17624	T25911	T25899	appos	CyA,lane
R17625	T25912	T25911	punct	",",CyA
R17626	T25913	T25929	compound	lane,lane
R17627	T25914	T25913	nummod	6,lane
R17628	T25915	T25913	punct	:,lane
R17629	T25916	T25918	compound	GP,CHX
R17630	T25917	T25918	compound	+,CHX
R17631	T25918	T25913	appos	CHX,lane
R17632	T25919	T25918	punct	",",CHX
R17633	T25920	T25913	parataxis	lane,lane
R17634	T25921	T25920	nummod	7,lane
R17635	T25922	T25913	punct	:,lane
R17636	T25923	T25924	nmod	GP,+
R17637	T25924	T25927	nmod	+,oligo
R17638	T25925	T25927	amod	unlabeled,oligo
R17639	T25926	T25927	compound	NFATP2/3,oligo
R17640	T25927	T25913	appos	oligo,lane
R17641	T25928	T25927	punct	",",oligo
R17642	T25929	T25873	appos	lane,A
R17643	T25930	T25929	nummod	8,lane
R17644	T25931	T25929	punct	:,lane
R17645	T25932	T25929	appos	water,lane
R17646	T25933	T25929	punct	),lane
R17647	T25934	T25936	advmod	as,as
R17648	T25935	T25936	advmod	well,as
R17649	T25936	T25929	cc	as,lane
R17650	T25937	T25939	det	a,summary
R17651	T25938	T25939	amod	graphical,summary
R17652	T25939	T25929	conj	summary,lane
R17653	T25940	T25939	prep	for,summary
R17654	T25941	T25943	det	the,site
R17655	T25942	T25943	compound	NFATP2/3,site
R17656	T25943	T25940	pobj	site,for
R17657	T25944	T25873	punct	",",A
R17658	T25945	T25957	csubjpass	depicting,displayed
R17659	T25946	T25947	det	a,decrease
R17660	T25947	T25945	dobj	decrease,depicting
R17661	T25948	T25947	prep	in,decrease
R17662	T25949	T25950	advmod	binding,following
R17663	T25950	T25951	amod	following,inhibition
R17664	T25951	T25948	pobj	inhibition,in
R17665	T25952	T25953	advmod	when,compared
R17666	T25953	T25945	advcl	compared,depicting
R17667	T25954	T25953	prep	to,compared
R17668	T25955	T25954	pobj	GP,to
R17669	T25956	T25957	auxpass	is,displayed
R17670	T25957	T25957	ROOT	displayed,displayed
R17671	T25958	T25957	punct	(,displayed
R17672	T25959	T25961	dep	*,p
R17673	T25960	T25961	punct	=,p
R17674	T25961	T25957	parataxis	p,displayed
R17675	T25962	T25963	nmod	<,0.05
R17676	T25963	T25961	npadvmod	0.05,p
R17677	T25964	T25961	punct	),p
R17678	T25965	T25957	punct	.,displayed
R17679	T25966	T25968	nsubjpass	Data,shown
R17680	T25967	T25968	auxpass	are,shown
R17681	T25968	T25968	ROOT	shown,shown
R17682	T25969	T25968	prep	as,shown
R17683	T25970	T25972	amod	mean,SEM
R17684	T25971	T25972	compound	±,SEM
R17685	T25972	T25969	pobj	SEM,as
R17686	T25973	T25976	punct	(,4
R17687	T25974	T25976	advmod	n,4
R17688	T25975	T25976	punct	=,4
R17689	T25976	T25972	nummod	4,SEM
R17690	T25977	T25976	punct	),4
R17691	T25978	T25968	punct	.,shown
R17692	T25979	T25988	nsubj	B,resulted
R17693	T25980	T25979	punct	",",B
R17694	T25981	T25979	conj	Inhibition,B
R17695	T25982	T25981	prep	of,Inhibition
R17696	T25983	T25982	pobj	NFκB,of
R17697	T25984	T25983	punct	",",NFκB
R17698	T25985	T25983	conj	NFAT,NFκB
R17699	T25986	T25985	cc	and,NFAT
R17700	T25987	T25985	conj	NFIL-6,NFAT
R17701	T25988	T25988	ROOT	resulted,resulted
R17702	T25989	T25988	prep	in,resulted
R17703	T25990	T25992	amod	decreased,mRNA
R17704	T25991	T25992	compound	IL-1RA,mRNA
R17705	T25992	T25989	pobj	mRNA,in
R17706	T25993	T25992	prep	following,mRNA
R17707	T25994	T25993	pobj	CHX,following
R17708	T25995	T25994	punct	",",CHX
R17709	T25996	T25994	conj	CAPE,CHX
R17710	T25997	T25996	cc	or,CAPE
R17711	T25998	T25996	conj	CyA,CAPE
R17712	T25999	T25988	prep	compared,resulted
R17713	T26000	T25999	prep	to,compared
R17714	T26001	T26000	pobj	GP,to
R17715	T26002	T25988	punct	.,resulted
R17716	T26003	T26005	nsubjpass	GAPDH,used
R17717	T26004	T26005	auxpass	is,used
R17718	T26005	T26005	ROOT	used,used
R17719	T26006	T26005	prep	as,used
R17720	T26007	T26008	compound	housekeeping,control
R17721	T26008	T26006	pobj	control,as
R17722	T26009	T26011	punct	(,gel
R17723	T26010	T26011	amod	representative,gel
R17724	T26011	T26008	appos	gel,control
R17725	T26012	T26008	punct	",",control
R17726	T26013	T26008	appos	n,control
R17727	T26014	T26015	punct	=,4
R17728	T26015	T26013	nummod	4,n
R17729	T26016	T26015	punct	),4
R17730	T26017	T26005	punct	.,used
R17731	T26018	T26028	nsubj	C,reduced
R17732	T26019	T26018	punct	",",C
R17733	T26020	T26018	appos	Inhibition,C
R17734	T26021	T26020	prep	of,Inhibition
R17735	T26022	T26021	pobj	NFκB,of
R17736	T26023	T26022	punct	",",NFκB
R17737	T26024	T26022	conj	NFAT,NFκB
R17738	T26025	T26024	cc	and,NFAT
R17739	T26026	T26024	conj	NFIL-6,NFAT
R17740	T26027	T26028	advmod	significantly,reduced
R17741	T26028	T26028	ROOT	reduced,reduced
R17742	T26029	T26030	det	the,production
R17743	T26030	T26028	dobj	production,reduced
R17744	T26031	T26030	prep	of,production
R17745	T26032	T26031	pobj	IL-1RA,of
R17746	T26033	T26028	prep	by,reduced
R17747	T26034	T26035	compound	human,PBMC
R17748	T26035	T26033	pobj	PBMC,by
R17749	T26036	T26028	prep	following,reduced
R17750	T26037	T26036	pobj	treatment,following
R17751	T26038	T26037	prep	with,treatment
R17752	T26039	T26038	pobj	CHX,with
R17753	T26040	T26039	punct	",",CHX
R17754	T26041	T26039	conj	CAPE,CHX
R17755	T26042	T26041	cc	or,CAPE
R17756	T26043	T26041	conj	CyA,CAPE
R17757	T26044	T26045	advmod	when,compared
R17758	T26045	T26028	advcl	compared,reduced
R17759	T26046	T26045	prep	to,compared
R17760	T26047	T26057	dep	GP,p
R17761	T26048	T26047	punct	(,GP
R17762	T26049	T26047	prep	*,GP
R17763	T26050	T26057	punct	=,p
R17764	T26051	T26057	ccomp	p,p
R17765	T26052	T26053	nmod	<,0.05
R17766	T26053	T26051	npadvmod	0.05,p
R17767	T26054	T26057	punct	;,p
R17768	T26055	T26057	punct	**,p
R17769	T26056	T26057	punct	=,p
R17770	T26057	T26046	pobj	p,to
R17771	T26058	T26059	nmod	<,0.01
R17772	T26059	T26057	npadvmod	0.01,p
R17773	T26060	T26057	punct	),p
R17774	T26061	T26028	punct	.,reduced
R17775	T26062	T26064	nsubjpass	Data,shown
R17776	T26063	T26064	auxpass	are,shown
R17777	T26064	T26064	ROOT	shown,shown
R17778	T26065	T26064	prep	as,shown
R17779	T26066	T26068	amod	mean,SEM
R17780	T26067	T26068	compound	±,SEM
R17781	T26068	T26065	pobj	SEM,as
R17782	T26069	T26068	punct	(,SEM
R17783	T26070	T26072	nmod	n,3
R17784	T26071	T26072	punct	=,3
R17785	T26072	T26068	prep	3,SEM
R17786	T26073	T26072	punct	),3
R17787	T26074	T26064	punct	.,shown
R7143	T10891	T10895	nsubj	Inhibition,led
R7144	T10892	T10891	prep	of,Inhibition
R7145	T10893	T10894	compound	transcription,factors
R7146	T10894	T10892	pobj	factors,of
R7147	T10895	T10895	ROOT	led,led
R7148	T10896	T10895	prep	to,led
R7149	T10897	T10899	amod	reduced,levels
R7150	T10898	T10899	compound	IL-1RA,levels
R7151	T10899	T10896	pobj	levels,to
R7152	T10900	T10901	amod	Pharmacological,inhibitors
R7153	T10901	T10903	nsubjpass	inhibitors,used
R7154	T10902	T10903	auxpass	were,used
R7155	T10903	T10895	conj	used,led
R7156	T10904	T10905	aux	to,demonstrate
R7157	T10905	T10903	xcomp	demonstrate,used
R7158	T10906	T10915	mark	that,are
R7159	T10907	T10910	det	the,sites
R7160	T10908	T10909	compound	transcription,factor
R7161	T10909	T10910	compound	factor,sites
R7162	T10910	T10915	nsubj	sites,are
R7163	T10911	T10910	prep	within,sites
R7164	T10912	T10914	det	the,promoter
R7165	T10913	T10914	compound	IL-1RA,promoter
R7166	T10914	T10911	pobj	promoter,within
R7167	T10915	T10905	ccomp	are,demonstrate
R7168	T10916	T10915	acomp	relevant,are
R7169	T10917	T10916	prep	for,relevant
R7170	T10918	T10919	det	the,induction
R7171	T10919	T10917	pobj	induction,for
R7172	T10920	T10919	prep	of,induction
R7173	T10921	T10920	pobj	IL-1RA,of
R7174	T10922	T10919	prep	by,induction
R7175	T10923	T10922	pobj	GP,by
R7176	T10924	T10903	punct	.,used
R7177	T10925	T10926	mark	As,expected
R7178	T10926	T10953	advcl	expected,overruled
R7179	T10927	T10953	punct	",",overruled
R7180	T10928	T10929	det	an,inhibition
R7181	T10929	T10953	nsubjpass	inhibition,overruled
R7182	T10930	T10929	prep	of,inhibition
R7183	T10931	T10930	pobj	NFκB,of
R7184	T10932	T10929	prep	via,inhibition
R7185	T10933	T10934	compound	CAPE,[
R7186	T10934	T10932	pobj	[,via
R7187	T10935	T10936	nummod	35,]
R7188	T10936	T10934	conj	],[
R7189	T10937	T10936	cc	and,]
R7190	T10938	T10936	conj	CyA,]
R7191	T10939	T10938	punct	",",CyA
R7192	T10940	T10938	conj	NFAT,CyA
R7193	T10941	T10934	prep	via,[
R7194	T10942	T10941	pobj	CyA,via
R7195	T10943	T10942	cc	and,CyA
R7196	T10944	T10942	conj	NFIL-6,CyA
R7197	T10945	T10929	prep	via,inhibition
R7198	T10946	T10947	compound	CHX,[
R7199	T10947	T10945	pobj	[,via
R7200	T10948	T10949	nummod	36,]
R7201	T10949	T10953	nsubjpass	],overruled
R7202	T10950	T10953	aux	could,overruled
R7203	T10951	T10953	neg	not,overruled
R7204	T10952	T10953	auxpass	be,overruled
R7205	T10953	T10953	ROOT	overruled,overruled
R7206	T10954	T10953	agent	by,overruled
R7207	T10955	T10954	pobj	GP,by
R7208	T10956	T10953	punct	",",overruled
R7209	T10957	T10953	advcl	leading,overruled
R7210	T10958	T10957	prep	to,leading
R7211	T10959	T10962	det	a,activity
R7212	T10960	T10962	amod	down-regulated,activity
R7213	T10961	T10962	amod	binding,activity
R7214	T10962	T10958	pobj	activity,to
R7215	T10963	T10962	prep	of,activity
R7216	T10964	T10966	det	the,factors
R7217	T10965	T10966	compound	transcription,factors
R7218	T10966	T10963	pobj	factors,of
R7219	T10967	T10962	prep	to,activity
R7220	T10968	T10970	det	the,sites
R7221	T10969	T10970	compound	IL-1RA,sites
R7222	T10970	T10967	pobj	sites,to
R7223	T10971	T10957	punct	",",leading
R7224	T10972	T10953	cc	and,overruled
R7225	T10973	T10974	det	a,reduction
R7226	T10974	T10953	conj	reduction,overruled
R7227	T10975	T10974	prep	of,reduction
R7228	T10976	T10977	compound	IL-1RA,mRNA
R7229	T10977	T10981	nmod	mRNA,levels
R7230	T10978	T10977	cc	and,mRNA
R7231	T10979	T10977	conj	IL-1RA,mRNA
R7232	T10980	T10981	compound	protein,levels
R7233	T10981	T10975	pobj	levels,of
R7234	T10982	T10981	punct	(,levels
R7235	T10983	T10981	appos	Fig.,levels
R7236	T10984	T10983	nummod	7,Fig.
R7237	T10985	T10983	punct	),Fig.
R7238	T10986	T10953	punct	.,overruled
R7239	T10987	T10988	det	The,extent
R7240	T10988	T10996	nsubjpass	extent,shown
R7241	T10989	T10988	prep	of,extent
R7242	T10990	T10989	pobj	reduction,of
R7243	T10991	T10990	prep	in,reduction
R7244	T10992	T10991	pobj	NFATP2/3,in
R7245	T10993	T10992	advmod	binding,NFATP2/3
R7246	T10994	T10996	auxpass	is,shown
R7247	T10995	T10996	advmod	exemplarily,shown
R7248	T10996	T10996	ROOT	shown,shown
R7249	T10997	T10996	prep	in,shown
R7250	T10998	T10999	det	an,autoradiogram
R7251	T10999	T10997	pobj	autoradiogram,in
R7252	T11000	T11002	punct	(,7A
R7253	T11001	T11002	compound	Fig.,7A
R7254	T11002	T10999	appos	7A,autoradiogram
R7255	T11003	T11002	punct	",",7A
R7256	T11004	T11002	acl	left,7A
R7257	T11005	T11004	npadvmod	side,left
R7258	T11006	T11002	punct	),7A
R7259	T11007	T10996	cc	and,shown
R7260	T11008	T11009	advmod	graphically,summarized
R7261	T11009	T10996	conj	summarized,shown
R7262	T11010	T11009	punct	(,summarized
R7263	T11011	T11013	advmod	n,4
R7264	T11012	T11013	punct	=,4
R7265	T11013	T11009	dobj	4,summarized
R7266	T11014	T11009	punct	",",summarized
R7267	T11015	T11016	compound	Fig.,7A
R7268	T11016	T11016	ROOT	7A,7A
R7269	T11017	T11019	punct	",",side
R7270	T11018	T11019	amod	right,side
R7271	T11019	T11016	appos	side,7A
R7272	T11020	T11016	punct	),7A
R7273	T11021	T10996	punct	.,shown
R7274	T11022	T11023	det	The,results
R7275	T11023	T11031	nsubj	results,were
R7276	T11024	T11023	prep	for,results
R7277	T11025	T11026	det	the,NFκB

bionlp-st-ge-2016-test-tees

Id	Subject	Object	Predicate	Lexical cue
T25573	2009-2016	Negative_regulation	denotes	reduced
T25572	2009-2016	Negative_regulation	denotes	reduced
T25571	2021-2031	Gene_expression	denotes	production
T25570	1959-1969	Negative_regulation	denotes	Inhibition
T25569	2035-2041	Protein	denotes	IL-1RA
T25568	1988-1994	Protein	denotes	NFIL-6
T25567	1979-1983	Protein	denotes	NFAT
T25566	1973-1977	Protein	denotes	NFκB
T25565	1889-1894	Protein	denotes	GAPDH
T25564	1824-1833	Negative_regulation	denotes	decreased
T25560	1805-1811	Protein	denotes	NFIL-6
T25559	1796-1800	Protein	denotes	NFAT
T25558	1790-1794	Protein	denotes	NFκB
T25557	1618-1631	Protein	denotes	NFATP2/3 site
T25556	1327-1334	Binding	denotes	binding
T25555	1327-1334	Binding	denotes	binding
T25554	1327-1334	Binding	denotes	binding
T25553	1276-1286	Negative_regulation	denotes	Inhibition
T25552	1276-1286	Negative_regulation	denotes	Inhibition
T25551	1342-1357	Protein	denotes	IL-1RA promoter
T25550	1316-1322	Protein	denotes	NFIL-6
T25549	1307-1311	Protein	denotes	NFAT
T25548	1301-1305	Protein	denotes	NFκB
T10855	1240-1249	Negative_regulation	denotes	decreased
T25563	1776-1786	Negative_regulation	denotes	Inhibition
T25562	1885-1887	Protein	denotes	GP
T25561	1834-1845	Protein	denotes	IL-1RA mRNA
T10831	303-309	Protein	denotes	NFIL-6
T10830	286-298	Protein	denotes	NFAT via CyA
T10829	267-284	Protein	denotes	CAPE [35] and CyA
T10828	258-262	Protein	denotes	NFκB
T10827	184-192	Positive_regulation	denotes	relevant
T10826	201-210	Positive_regulation	denotes	induction
T10825	224-226	Protein	denotes	GP
T10824	214-220	Protein	denotes	IL-1RA
T10823	164-179	Protein	denotes	IL-1RA promoter
T10822	43-50	Negative_regulation	denotes	reduced
T10821	51-57	Protein	denotes	IL-1RA
T10854	1146-1156	Positive_regulation	denotes	pronounced
T10853	1257-1264	Localization	denotes	release
T10852	1164-1171	Binding	denotes	binding
T10851	1118-1128	Negative_regulation	denotes	inhibition
T10850	1250-1256	Protein	denotes	IL-1RA
T10849	1113-1117	Protein	denotes	NFκB
T10848	1047-1053	Gene_expression	denotes	levels
T10847	1047-1053	Gene_expression	denotes	levels
T10846	1084-1087	Protein	denotes	Fig
T10845	1068-1070	Protein	denotes	GP
T10844	1032-1046	Protein	denotes	IL-1RA protein
T10843	908-916	Negative_regulation	denotes	decrease
T10842	988-991	Protein	denotes	Fig
T10841	920-926	Protein	denotes	IL-1RA
T10840	771-785	Protein	denotes	highest IL-1RA
T10839	707-727	Protein	denotes	NFIL-6 binding sites
T10838	698-702	Protein	denotes	NFκB
T10837	454-463	Negative_regulation	denotes	reduction
T10836	454-463	Negative_regulation	denotes	reduction
T10835	244-254	Negative_regulation	denotes	inhibition
T10834	244-254	Negative_regulation	denotes	inhibition
T10833	483-497	Protein	denotes	IL-1RA protein
T10832	467-478	Protein	denotes	IL-1RA mRNA
R17297	T25548	T25552	themeOf	NFκB,Inhibition
R17298	T25548	T25555	themeOf	NFκB,binding
R17299	T25549	T25553	themeOf	NFAT,Inhibition
R17300	T25549	T25556	themeOf	NFAT,binding
R17301	T25551	T25554	themeOf	IL-1RA promoter,binding
R17302	T25551	T25555	themeOf	IL-1RA promoter,binding
R17303	T25551	T25556	themeOf	IL-1RA promoter,binding
R17304	T25558	T25563	themeOf	NFκB,Inhibition
R17305	T25561	T25564	themeOf	IL-1RA mRNA,decreased
R17306	T25566	T25570	themeOf	NFκB,Inhibition
R17307	T25567	T25572	causeOf	NFAT,reduced
R17308	T25568	T25573	causeOf	NFIL-6,reduced
R17309	T25569	T25571	themeOf	IL-1RA,production
R17310	T25571	T25572	themeOf	production,reduced
R17311	T25571	T25573	themeOf	production,reduced
R7115	T10821	T10822	themeOf	IL-1RA,reduced
R7116	T10824	T10826	themeOf	IL-1RA,induction
R7117	T10825	T10826	causeOf	GP,induction
R7118	T10826	T10827	themeOf	induction,relevant
R7119	T10828	T10834	themeOf	NFκB,inhibition
R7120	T10829	T10835	themeOf	CAPE [35] and CyA,inhibition
R7121	T10832	T10836	themeOf	IL-1RA mRNA,reduction
R7122	T10833	T10837	themeOf	IL-1RA protein,reduction
R7123	T10841	T10843	themeOf	IL-1RA,decrease
R7124	T10844	T10847	themeOf	IL-1RA protein,levels
R7125	T10845	T10848	themeOf	GP,levels
R7126	T10849	T10851	themeOf	NFκB,inhibition
R7127	T10849	T10852	themeOf	NFκB,binding
R7128	T10850	T10853	themeOf	IL-1RA,release
R7129	T10852	T10854	themeOf	binding,pronounced
R7130	T10853	T10855	themeOf	release,decreased

testone

Id	Subject	Object	Predicate	Lexical cue
T25443	1307-1311	Protein	denotes	NFAT
T25465	2056-2065	Positive_regulation	denotes	following
T25464	2021-2031	Gene_expression	denotes	production
T25463	2009-2016	Negative_regulation	denotes	reduced
T25462	1846-1855	Positive_regulation	denotes	following
T25461	1824-1833	Negative_regulation	denotes	decreased
T25460	1812-1820	Positive_regulation	denotes	resulted
T25459	1657-1664	Binding	denotes	binding
T25458	1645-1653	Negative_regulation	denotes	decrease
T25457	1627-1631	Entity	denotes	site
T25456	1349-1357	Entity	denotes	promoter
T25455	1327-1334	Binding	denotes	binding
T25454	1293-1300	Positive_regulation	denotes	induced
T25453	1276-1286	Negative_regulation	denotes	Inhibition
T25452	2035-2041	Protein	denotes	IL-1RA
T25451	1988-1994	Protein	denotes	NFIL-6
T25450	1979-1983	Protein	denotes	NFAT
T25449	1889-1894	Protein	denotes	GAPDH
T25448	1834-1840	Protein	denotes	IL-1RA
T25447	1805-1811	Protein	denotes	NFIL-6
T25446	1796-1800	Protein	denotes	NFAT
T25445	1342-1348	Protein	denotes	IL-1RA
T25444	1316-1322	Protein	denotes	NFIL-6
T10395	1257-1264	Localization	denotes	release
T10394	1240-1249	Negative_regulation	denotes	decreased
T10393	1231-1234	Positive_regulation	denotes	led
T10392	1164-1171	Binding	denotes	binding
T10391	908-916	Negative_regulation	denotes	decrease
T10390	551-558	Binding	denotes	binding
T10389	529-538	Negative_regulation	denotes	reduction
T10388	454-463	Negative_regulation	denotes	reduction
T10387	441-446	Entity	denotes	sites
T10386	381-388	Binding	denotes	binding
T10385	366-380	Negative_regulation	denotes	down-regulated
T10384	336-345	Negative_regulation	denotes	overruled
T10383	291-294	Positive_regulation	denotes	via
T10382	201-210	Positive_regulation	denotes	induction
T10381	140-146	Entity	denotes	factor
T10380	43-50	Negative_regulation	denotes	reduced
T10379	1250-1256	Protein	denotes	IL-1RA
T10378	1032-1038	Protein	denotes	IL-1RA
T10377	920-926	Protein	denotes	IL-1RA
T10376	779-785	Protein	denotes	IL-1RA
T10375	483-489	Protein	denotes	IL-1RA
T10374	467-473	Protein	denotes	IL-1RA
T10373	434-440	Protein	denotes	IL-1RA
T10372	303-309	Protein	denotes	NFIL-6
T10371	286-290	Protein	denotes	NFAT
T10370	214-220	Protein	denotes	IL-1RA
T10369	164-170	Protein	denotes	IL-1RA
T10368	51-57	Protein	denotes	IL-1RA
R17237	T25443	T25455	themeOf	NFAT,binding
R17238	T25444	T25455	themeOf	NFIL-6,binding
R17239	T25448	T25461	themeOf	IL-1RA,decreased
R17240	T25451	T25463	causeOf	NFIL-6,reduced
R17241	T25452	T25464	themeOf	IL-1RA,production
R17242	T25454	T25453	themeOf	induced,Inhibition
R17243	T25455	T25454	themeOf	binding,induced
R17244	T25456	T25455	themeOf	promoter,binding
R17245	T25456	T25445	partOf	promoter,IL-1RA
R17246	T25459	T25458	themeOf	binding,decrease
R17247	T25461	T25460	themeOf	decreased,resulted
R17248	T25464	T25465	themeOf	production,following
R17249	T25464	T25463	themeOf	production,reduced
R6805	T10370	T10382	themeOf	IL-1RA,induction
R6806	T10372	T10383	causeOf	NFIL-6,via
R6807	T10374	T10388	themeOf	IL-1RA,reduction
R6808	T10377	T10391	themeOf	IL-1RA,decrease
R6809	T10379	T10395	themeOf	IL-1RA,release
R6810	T10386	T10385	themeOf	binding,down-regulated
R6811	T10390	T10389	themeOf	binding,reduction
R6812	T10394	T10393	themeOf	decreased,led
R6813	T10395	T10394	themeOf	release,decreased

test3

Id	Subject	Object	Predicate	Lexical cue
T25499	2056-2065	Positive_regulation	denotes	following
T25498	2035-2041	Protein	denotes	IL-1RA
T25497	2021-2031	Gene_expression	denotes	production
T25496	2009-2016	Negative_regulation	denotes	reduced
T25495	1988-1994	Protein	denotes	NFIL-6
T25494	1979-1983	Protein	denotes	NFAT
T25493	1959-1969	Negative_regulation	denotes	Inhibition
T25492	1889-1894	Protein	denotes	GAPDH
T25491	1846-1855	Positive_regulation	denotes	following
T25490	1834-1840	Protein	denotes	IL-1RA
T25489	1824-1833	Negative_regulation	denotes	decreased
T25488	1812-1820	Positive_regulation	denotes	resulted
T25487	1805-1811	Protein	denotes	NFIL-6
T25486	1796-1800	Protein	denotes	NFAT
T25485	1776-1786	Negative_regulation	denotes	Inhibition
T25484	1657-1664	Binding	denotes	binding
T25483	1645-1653	Negative_regulation	denotes	decrease
T25482	1349-1357	Entity	denotes	promoter
T25481	1342-1348	Protein	denotes	IL-1RA
T25480	1327-1334	Binding	denotes	binding
T25479	1316-1322	Protein	denotes	NFIL-6
T25478	1307-1311	Protein	denotes	NFAT
T25477	1293-1300	Positive_regulation	denotes	induced
T25476	1276-1286	Negative_regulation	denotes	Inhibition
T25475	2035-2041	Protein	denotes	IL-1RA
T25474	1988-1994	Protein	denotes	NFIL-6
T25473	1979-1983	Protein	denotes	NFAT
T25472	1889-1894	Protein	denotes	GAPDH
T25471	1834-1840	Protein	denotes	IL-1RA
T25470	1805-1811	Protein	denotes	NFIL-6
T25469	1796-1800	Protein	denotes	NFAT
T25468	1342-1348	Protein	denotes	IL-1RA
T25467	1316-1322	Protein	denotes	NFIL-6
T25466	1307-1311	Protein	denotes	NFAT
T10435	1257-1264	Localization	denotes	release
T10434	1250-1256	Protein	denotes	IL-1RA
T10433	1240-1249	Negative_regulation	denotes	decreased
T10432	1231-1234	Positive_regulation	denotes	led
T10431	1164-1171	Binding	denotes	binding
T10430	1032-1038	Protein	denotes	IL-1RA
T10429	938-948	Negative_regulation	denotes	inhibition
T10428	920-926	Protein	denotes	IL-1RA
T10427	908-916	Negative_regulation	denotes	decrease
T10426	779-785	Protein	denotes	IL-1RA
T10425	551-558	Binding	denotes	binding
T10424	529-538	Negative_regulation	denotes	reduction
T10423	483-489	Protein	denotes	IL-1RA
T10422	467-473	Protein	denotes	IL-1RA
T10421	454-463	Negative_regulation	denotes	reduction
T10420	434-440	Protein	denotes	IL-1RA
T10419	381-388	Binding	denotes	binding
T10418	366-380	Negative_regulation	denotes	down-regulated
T10417	336-345	Negative_regulation	denotes	overruled
T10416	310-313	Positive_regulation	denotes	via
T10415	303-309	Protein	denotes	NFIL-6
T10414	291-294	Positive_regulation	denotes	via
T10413	286-290	Protein	denotes	NFAT
T10412	214-220	Protein	denotes	IL-1RA
T10411	201-210	Positive_regulation	denotes	induction
T10410	164-170	Protein	denotes	IL-1RA
T10409	51-57	Protein	denotes	IL-1RA
T10408	43-50	Negative_regulation	denotes	reduced
T10407	1250-1256	Protein	denotes	IL-1RA
T10406	1032-1038	Protein	denotes	IL-1RA
T10405	920-926	Protein	denotes	IL-1RA
T10404	779-785	Protein	denotes	IL-1RA
T10403	483-489	Protein	denotes	IL-1RA
T10402	467-473	Protein	denotes	IL-1RA
T10401	434-440	Protein	denotes	IL-1RA
T10400	303-309	Protein	denotes	NFIL-6
T10399	286-290	Protein	denotes	NFAT
T10398	214-220	Protein	denotes	IL-1RA
T10397	164-170	Protein	denotes	IL-1RA
T10396	51-57	Protein	denotes	IL-1RA
R17250	T25478	T25480	themeOf	NFAT,binding
R17251	T25479	T25480	themeOf	NFIL-6,binding
R17252	T25480	T25477	themeOf	binding,induced
R17253	T25482	T25480	themeOf	promoter,binding
R17254	T25482	T25481	partOf	promoter,IL-1RA
R17255	T25484	T25483	themeOf	binding,decrease
R17256	T25485	T25488	causeOf	Inhibition,resulted
R17257	T25485	T25489	causeOf	Inhibition,decreased
R17258	T25486	T25488	causeOf	NFAT,resulted
R17259	T25486	T25489	causeOf	NFAT,decreased
R17260	T25486	T25485	themeOf	NFAT,Inhibition
R17261	T25487	T25489	causeOf	NFIL-6,decreased
R17262	T25487	T25485	themeOf	NFIL-6,Inhibition
R17263	T25487	T25488	causeOf	NFIL-6,resulted
R17264	T25489	T25488	themeOf	decreased,resulted
R17265	T25490	T25489	themeOf	IL-1RA,decreased
R17266	T25493	T25496	causeOf	Inhibition,reduced
R17267	T25494	T25493	themeOf	NFAT,Inhibition
R17268	T25494	T25496	causeOf	NFAT,reduced
R17269	T25495	T25493	themeOf	NFIL-6,Inhibition
R17270	T25495	T25496	causeOf	NFIL-6,reduced
R17271	T25497	T25499	themeOf	production,following
R17272	T25497	T25496	themeOf	production,reduced
R17273	T25498	T25497	themeOf	IL-1RA,production
R6814	T10409	T10408	themeOf	IL-1RA,reduced
R6815	T10412	T10411	themeOf	IL-1RA,induction
R6816	T10415	T10414	causeOf	NFIL-6,via
R6817	T10419	T10418	themeOf	binding,down-regulated
R6818	T10422	T10421	themeOf	IL-1RA,reduction
R6819	T10423	T10421	themeOf	IL-1RA,reduction
R6820	T10425	T10424	themeOf	binding,reduction
R6821	T10428	T10427	themeOf	IL-1RA,decrease
R6822	T10429	T10427	causeOf	inhibition,decrease
R6823	T10434	T10435	themeOf	IL-1RA,release
R6824	T10435	T10433	themeOf	release,decreased

PMC:1472690 / 21540-23726 JSONTXT

Annnotations TAB JSON ListView MergeView

PMC:1472690 / 21540-23726 JSON TXT